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Abstrakt / Abstract
Cerebrovaskulární reaktivita (CVR) je auto-
regulační machanizmus udržující konstantní
mozkový krevní tok a změny v CVR jsou indi-
kátorem patologií mozkových cév. Reaktivita
se dá měřit neinvazivně pomocí BOLD fMRI
s hyperkapnickou stimulací. V této práci je
popsán postup pro automatické zpracování
dat naměřených pomocí BOLD při hyperkap-
nické stimulaci. Byly navrženy dvě metody a
jejich výsledky jsou mezi sebou porovnány na
skupině pacietů se stenózou.
První metoda (MDA) využívá jako regresor
pro regresní analýzu (metoda nejmenších
čtverců - MNČ) blokovou funkci s korekcí
posunu konvolvonanou s hemodynamickou
odezvou. Druhá metoda (DDA) využívá re-
gresor, který by měl vykazovat lepší efektivitu
v případě, že pacient není schopný přesně
dodržet pokyny pro držení dechu a výdech
v průběhu měření. Je založena na porovnání
odezev z několika vaskulárních regionů pomocí
pearsonova korelačního koeficientu (PCC), re-
gion s nejlepší korelací vůči standardní odezvě
je použit jako regresor pro MNČ.
Výsledné CVR mapy byly hodnoceny skupi-
nou lékařů (58 subjektů) a lékařským fyzikem
(153 měření na 85 subjektech). Všem hodnotí-
cím byl zamezen přístup ke klinickým datům
hodnocených subjeků. Byla hodnocena celková
kvalita výsledných CVR map a jejich dignos-
tický potenciál. Kvalita byla hodnocena stupni
0-2 (0–nečitelné, 1–čitelné, 2–optimální). Me-
toda DDA snížila počet nečitelných případů z
12% na 3% (153 měření) a z 17% na 10% (58
subjektů). Kvalita se zlepšila v 39% případů
(z 31, které byly v MDA hodnoceny 0 a 1) a
76% případů (z 42, které byly v MDA metodě
hodnoceny jako 0 nebo 1). DDA poskytuje ro-
zumné výsledky i v případech, kde standardní
(MDA) metoda nestačí a je tak možným ná-
stojem pro měření CVR v klinické praxi.
Klíčová slova: Cerebrovaskulární reakivita;
hyperkapnie; zadržení dechu; BOLD; fMRI;
Cerebrovascular reactivity (CVR) is an
autoregulatory mechanism that maintains
constant cerebral blood flow. Impaired CVR
is an indicator of pathologies of brain-feeding
arteries. CVR can be assessed non-invasively
using a BOLD functional MRI under hyper-
capnic conditions. In this thesis, we have
implemented an automatic pipeline for pro-
cessing of hypercapnia BOLD data using a
standard method and a novel data-driven
method. Their performance was compared on
a group of patients with stenosis.
The standard model-driven approach (MDA)
use a block function convolved with a haemo-
dynamic response function as a regressor for
CVR response evaluation. The data-driven
approach (DDA) first uses Pearsons correla-
tion coefficient (PCC) of the standard regres-
sor with a mean responses of several selected
regions to determine a region with an optimal
response. The mean response of this region
is then used as a regressor for the CVR analy-
sis. This should be more efficient in case where
the subject does not adhere to the breathing-
protocol completely.
The CVR-maps were evaluated by a board
of physicians (58 subjects) and by a med-
ical physicist (85 subjects on 153 sessions)
blinded from clinical findings. The overall
image quality was scored on both methods
grading from 0-2 (0 unreadable, 1 suboptimal,
2 optimal quality). The unreadable cases
were reduced from 12% in MDA to 3% in
DDA (153 sessions) and from 17% to 10%
(58 sessions). The quality improved in 39%
cases (out of 31 session that scored 0 or 1 on
MDA; physicians) and in 76% cases (out of 42
session that scored 0 or 1 on MDA; physicist).
DDA is a promising tool to assess CVR in
clinical population. It gives reasonable results
in a large number of cases where the standard
analysis completely fails.
Keywords: Cerebrovascular reactivity; hy-
percapnia; breath holding; BOLD; fMRI;
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Chapter 1
Introduction
Today’s hectic and stressful lifestyle brings many diseases of aﬄuence. Cardiovascular
diseases are the major cause of death worldwide with cerebrovascular diseases (strokes)
being the cause of death in around 10% of cases1). The most common type of stroke
is an ischemic stroke with around 80% of cases, the other 20% cases are hemorrhagic
strokes 2). Seventy percents of all ischemics strokes occur in the anterior circulation
and 90% of anterior circulation strokes aﬄicts middle cerebral artery (MCA) and its
branches 3). MCA is the largest intracerebral vessel that supply almost the whole lateral
surface of the hemispheres. This makes measurements of brain perfusion, diffusion,
neuronal activity, and vessel condition an important diagnostic tool. In the past, the
information about brain function was acquired solely by positron emission tomography
(PET), single proton emission computed tomography (SPECT) and magnetic resonance
imaging (MRI) using contrast agents.
Nowadays, there is a wide range of MRI methods for imaging the brain function and
metabolism and state of vessels without the use of contrast agents. The development of
new sequences and shorter acquisition times makes the functional magnetic resonance
imaging (fMRI) one of the commonly used methods. The blood flow in vessels can
be also measured by time-of-flight angiography. Neuronal activation can be indirectly
assessed by blood oxygen level dependent (BOLD) fMRI and together with arterial
spin labelling (ASL) that measures the cerebral blood flow (CBF), the rate of oxygen
metabolism can be as well assessed. Recently, a new method for measuring cerebral
vessel reactivity (cerebrovascular reactivity, CVR) emerged that monitors the BOLD
signal changes under conditions of varying concentration of CO2 in blood [1–2].
The basic scheme of the CVR map acquisition based on CO2 stimulation is the following:.BOLD signal (sensitive to level of blood oxygenation) is acquired during normal
breathing..Change in blood CO2 is induced by breath hold or by inhalation of CO2 enriched
gas.. Increased concentration of CO2 in vessels changes the vessel diameter. This leads to
change in blood flow and other auto regulation mechanisms..Change in blood flow is observed through change in BOLD signal intensity..The whole process is repeated several times to make the measurement robust to noise.
The most reliable and reproducible results are obtained by automatic administration
of mixture of CO2 and air and by measuring the end-tidal pressure of CO2. However,
it is the patient comfort that is sacrificed by wearing an air-tight mask. Moreover, the
necessary hardware equipment for this is not readily available on most clinical sites.
1) http://www.who.int/whr/2004/annex/topic/en/annex 2 en.pdf
2) http://www.healthknowledge.org.uk/public-health-textbook/disease-causation-diagnostic/
2b-epidemiology-diseases-phs/chronic-diseases/stroke
3) http://emedicine.medscape.com/article/1159900-overview
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Breath-holding, on the other hand is more convenient from several points of view. It
increases patient comfort, speeds up the measurement by reducing technical prepa-
rations (manipulation with mask and gases). Recently, Pillai and Mikulis published a
review article suggesting that availability and comfort of a simple breath-hold technique
makes up for most of its limitations and is sufficient for most applications except for
pre-surgical planning [3]. The disadvantage of breath-holding is that the data analysis
fails in the case when the patient does not adhere completely to the breathing protocol.
Delayed reaction to a command, breathing normally during a breath-hold phase, etc.
can completely spoil the standard analysis. We have therefore aimed at designing a
robust method for data analyzis that would deliver reliable CVR maps even when the
patient’s cooperation was not optimal.
This thesis has the following goals:.Design and implement a pipeline for automatic processing of hypercapnia BOLD
data. The inputs are BOLD EPI and FLAIR images in DICOM format and the
output is a CVR-map overlayed over a FLAIR image normalized to the MNI template.. Implement a standard evaluation of the vascular response assuming the block design
experiment. Correct for individual delays in the patients response to commands.. Implement a novel data-driven approach which robustly evaluates the data even when
the subject is not following the measurement protocol precisely..Perform the analysis on a group of patients to provide an additional information for
a clinical study of patients with cerebrovascular pathology..Compare the quality of the CVR-maps for the standard and novel analysis method
and evaluate if the same regions are shown as pathological by the two methods.
2
Chapter 2
Background
This chapter introduces basic principles behind the study. It covers topics from MRI
physics and image acquisition to physiology and metabolism. To fully understand the
physiology of brain cells or the physics behind MRI we kindly refer the reader to the
publications dedicated to each mentioned topic to get more detailed information and
deeper description.
2.1 MRI basic
Magnetic resonance imaging is a medical imaging modality that allows imaging of soft
tissues. It uses the phenomena that a nuclei in external magnetic field can absorb
and re-emit electromagnetic radiation at frequency that depends on the strength of the
external magnetic field. In this section, the basics of MRI are covered.
2.1.1 History
The phenomena of nuclear magnetic resonance was first described by Isidor Rabi in
1938 (awarded the Nobel prize in Physics in 1944 for his discovery). In 1946, Felix
Bloch and Edward Mills Purcell discovered that a detectable signal can occur when a
sample is placed in a static magnetic field and irradiated by a radio-frequency pulse
with certain frequency – the Larmor frequency – and they have extended Rabi’s theory
to liquids and solids [4] (awarded the Nobel prize in Physics in 1952). However, it was
only during the last decades of 20th century that the magnetic resonance imaging was
developed and the first MRI device was built.
Raymond Damar in 1971 discovered that certain mouse tumors displayed elevated re-
laxation times. He built with his colleagues a superconducting magnet and made a
first human body image. They named the device FONAR (Field fOcussing Nuclear
mAgnetic Resonance).
In 1973, Paul Lauterbur discovered that use of linear gradients in magnetic field en-
ables to spatially encode the origin of an NMR signal. He made several measurements
in the presence of gradients with different directions and reconstructed a two dimen-
sional image of tissue proton density. For demonstration, he used tubes filled with
ordinary water surrounded by heavy water. MR was the only imaging method that
was able to differentiate between ordinary and heavy water. In the year of 1974, Sir
Peter Mansfeld’s group invented a slice-selective excitation. Later, they have also in-
vented a rapid imaging method based on very fast gradient variations – echo planar
imaging (EPI) – that is currently used in fMRI. These contributions in MR imaging
development were recognized by the Nobel committee and in 2003 the Nobel Prize in
Physiology or Medicine was awarded to Paul Lauterbur and Peter Mansfeld. Two No-
bel Prizes in chemistry were awarded in 1991 to Richard Ernst and in 2002 to Kurt
3
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Wüthrich. Richard Ernst’s group developed a two dimensional Fourier transform imag-
ing in 1975. This was an essential step for bringing the method to praxis because it
eliminated the unsharpness of the Lauterbur’s back-projection and thus lowered the
demands on magnet homogeneity. He was awarded the Nobel Prize for contributions in
high resolution nuclear magnetic resonance spectroscopy (MRS). Kurt Wüthrich was
honored for research in MRS for determination of the three dimensional structure of
biological macromolecules in solution.
The first image of a human head was acquired with MRI in 1978. And a first commer-
cial clinical superconducting system (Neptune 0.15 T ) was installed at Hammersmith
Hospital in London. In 1984, first 1.5 T systems were introduced. However, problems
with low SNR ratio, resolution and high sensitivity to noise and motion caused that
MR was not common until 1990s [5–7].
During the 90s, the scanners became more frequent in clinical praxis and MRI went
through a rapid development when clinical scanners with field strength of up to 7
T , stronger gradients and better coils were developed. However, the development on
the software side was equally important. In the last 20 years, a big variety of new
imaging sequences were introduced that allowed both faster and more precise imaging,
and imaging of neuronal activation, blood flow in vessels, diffusion, perfusion as well
as imaging of other tissue properties such as magnetization transfer, tissue relaxation,
magnetic susceptibility, 3D spectroscopy and many more.
2.1.2 Physics
NMR is a phenomenon in which protons with non-zero spin placed in a magnetic field
can absorb and re-transmit electromagnetic radiation at certain frequency. This can
be used to non-invasively image proton-density and other magnetic properties of tissue.
When a proton is placed in a magnetic field, the nuclear spins are polarized - aligned
with (lower energy state) or against (higher energy state) the direction of the field. A
static magnetic field is in literature marked as B0 an defined on orthogonal coordinate
system x, y and z where B0 is parallel to the z direction. The total magnetization of
all the protons is denoted as M. The total magnetization cannot be measured directly.
Instead, the M is diverted from the B0. It then starts to precess around it at Larmor
frequency ω, which is proportional to the magnitude of corresponding magnetization
vector (eq. (2.1)). This induces current in a receiver coil placed perpendicular to the
xy plane which serves as a measure for the total magnetization M and is perpendicular
to the z direction.
ω = γ · |B|, (2.1)
where ω0 is Larmor frequency [rad · s−1], γ is the gyromagnetic ratio [rad · s−1 · T−1]
(for hydrogen H1 267.513 · 106) and B0 main magnetic field [T ] [5, p. 139].
The vector M is diverted from the direction of B0 by applying an oscillating magnetic
field B1 perpendicular to B0. If the frequency of oscillation of B1 matches Larmor
frequency ω0, the magnetization vector M will start rotating around the axis of B1
at frequency ω1 = γ · |B1|. The B1 field is applied only for a short time at certain
amplitude allowing to rotate the M vector to the transversal xy plane. The B1 field is
emulated by an RF pulse with ω0 frequency emitted from a coil perpendicular to B0.
4
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Figure 2.1. T1 and T2 decay [5].
After the B1 field is turned off, the flipped vector M continues to precess around B0
and can be measured.
The measurable signal (Mx,y component of the magnetization M) decays exponentially
with time constant T2 (or T2* when the B0 field is not completely homogeneous) be-
cause of dephasing of its individual components. The Z-component of the magnetization
returns back to equilibrium with time constant T1, see Figure 2.1 and Table 2.1. The
changes in the magnetization during excitation and relaxation are fully described by
Bloch equation ((9.1) see attachment). Reduced version for the case when system was
initially in equilibrium and the RF pulse was 90◦ pulse (the flip angle is controlled by
the amplitude and duration of the B1 RF excitation pulse) along the +X axis (i.e.
Mx(0) = Mz(0) = 0 and My(0) = M0) the relaxation is described as:
Mx(t) = M0 sin(ωt) · e−tT2 My(t) = M0 cos(ωt) · e−tT2 Mz(t) = M0(1− e−tT1 ), (2.2)
where M = (Mx,My,Mz), ω is the Larmor frequency (2.1), and M0 is the steady state
magnetization [5].
By changing the echo-time (TE) between the excitation and measurement, and the
repetition time TR between the consecutive excitations, we make the measured signal
dependent on the proton density or based on the T1 and T2 properties of the tissue.
T1 [ms] T2 [ms]
Tissue 0.5 T 1.5 T 3 T 0.5 T 1.5 T 3 T
WM 520 560 832 107 82 110
GM 780 1100 1331 110 92 80
CSF - 2060 3700 - - -
Muscle 560 1075 898 34 33 29
Fat 132 200 382 108 - 68
Table 2.1. Relaxation times for different tissues at various field strength. Note that values
were measured in-vivo from human tissues and the table is composition of values from
various authors [5].
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To be able to obtain 3D images of tissue, the NMR signal needs to be spatially encoded
(Figure 2.2). This is done using gradient magnets, that are superimposed on the main
magnetic field B0 and changes linearly their strength along a given direction. The first
step is called slice-selection. The gradient is applied in a chosen direction (along z-axis
for example) and an RF-pulse with a narrow bandwith is applied. That way we are able
to rotate the M vector only in a given slice (depends on the strength of the gradient
and bandwidth of the RF-pulse) and the rest of the volume stays intact. This way,
the protons are excited and the signal measured only in a selected slice. Following
the excitation, another gradient (e.g. along y-axis) is turned on for short time only,
thus modifying the phase of precession depending on the spatial position on the y-axis.
During the signal readout, the gradient is applied in the third ortogonal direction (e.g.
along x-axis). This spatially modifies the signal frequency. This process is repeated
for several different phase-encoding steps for each slice and the images are obtain by
Fourier transformation of the measured signal. Please refer to the following publication
for more information on MRI physics [5–6].
Figure 2.2. Frequence and Phase Encod-
ing. 1)
Figure 2.3. MRI Scanner Gradient Coils.
2)
2.1.3 Hardware
The basic parts of MRI scanner are the magnet, the gradients and the RF system.
Together they form three kinds of magnetic fields - the main field of the scanner, the
gradients and the oscillating magnetic field of RF pulses. The magnet can be permanent
(up to 0.4 T ) or superconducting to generate large homogeneous magnetic field (the
strength can vary up to 7 T for clinical use and up to 21 T for research). Gradient coils
(Figure 2.3) are usually resistive electromagnets which provides rapid and precise change
of field strength in X, Y and Z direction and are used for encoding the spatial position
of the NMR signal. RF system employs transmitter, coil and receiver and is used for
both excitation and signal measurement. Another important parts are shim coils. Shim
coils are used to dynamically adjust the homogeneity of the static magnetic field, as
every subject or phantom placed in the magnet can caused inhomogeneities in the main
magnetic field which then lowers the SNR or cause artifacts in the measurements [5].
2.1.4 Imaging sequences
Normally, the proton density of the brain tissue is displayed with MRI. However, with
the change of imaging parameters as TR and TE (echo-time between the excitation
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and measurement) we can display other properties of the tissue. By selecting a short
TR, the Mz component does not fully relax to equilibrium before next excitation and
the intensity of the measured signal becomes dependent on the T1-time of the tissue
- such image is called T1-weighted. By prolonging TE, the difference in T2-times
becomes important and such images are then T2-weighted. By using a 180◦ excitation
pulse followed by a 90◦ pulse, we are able to suppress signal from tissue that has T1
time close to the delay between the 180◦ and 90◦ pulses. Such principle is used in
the fluid attenuated inversion recovery (FLAIR) sequences, where signal in fluids is
effectively suppressed. The fMRI images are typically acquired using so-called single-
shot acquisition sequences that acquire whole image slice in a single excitation. This
allows very fast imaging (order of seconds for whole brain) at the expense of decreased
resolution and image deformations. With such sequences we are able to monitor changes
in brain with very high time-resolution.
2.2 Brain physiology and anatomy
Brain, as other organs, needs to be surrounded by constant environment and be provided
with energy supply to work properly. Energy supply and waste is carried in and out,
respectively, by blood. The brain weight is around 1350 grams (approximately 2% of
total body weight). However, it receives 15% of the cardiac output, 20% of total body
oxygen consumption, and 25% of total body glucose utilization [8]. Glucose and oxygen
are consumed for energy production and as waste product the carbon dioxide, water and
other substances are produced. Most of the incoming O2, glucose and CO2 are consumed
and produced, respectively, in the gray matter which has higher concentration of the
neuronal cell bodies than the white matter which consists mostly of myelinated axons
and consumes significantly less [9].
2.2.1 Neurovascular Coupling
Neurovascular coupling (NVC) is a relationship between local neural activity and
changes in cerebral blood flow. It ensure that all substances such as oxygen, glucose
are provided to the neurons when needed.
When a neuron communicate with another neuron, energy in the form of adenosine
triphosphate (ATP) is consumed. The ATP is synthesized by oxygen and glucose
metabolism. This leads to their local deficit and triggers a local increase of blood
flow caused by dilatory reaction of capillaries (Figure 2.4). The exact nature of the
signaling process is, however, not yet fully understood [10].
2.2.2 Cerebral blood flow
CBF is the amount of blood floating through the brain per a time unit. The total CBF
in the whole brain is usually estimated as 750-1000 millilitres per minute in adults or
15% of the cardiac output. This equals to around 55 to 60 millilitres of blood per 100
grams of brain tissue per minute. CBF is almost two times higher in gray matter 75
ml/100g/min than in white matter 45 ml/100g/min [11].
CBF depends on a number of factors that can be broadly divided in two groups. Those
affecting cerebral perfusion pressure (CPP) or those affecting the radius of cerebral
vessels (for example dilatory reaction of veins to CO2).
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Neural activation
Neurotransmitter release
(e.g., glutamate, GABA)
ATP
consumption
Oxygen consumption
Glucose consumption
Vasoactive chemicals
agents, metabolites
(e.g., K+, NO, adenosine)
Cerebral
Blood Flow
Figure 2.4. Neurovascular coupling diagram. Neural activation leads to several effects
- increase in consumption of oxygen, glucose and energy stored in ATP molecules and
release of transmitters. All these effects are part of signaling pattern that leads to release
of vasoactive agents - dilatation of vessels and increase in blood flow. 1)
Too low CBF leads to ischemia or even tissue death. Too high CBF can raise cere-
bral blood volume and intracranial pressure and this state can develop intra cranial
haematoma or cerebral edema. A constant flow brain in healthy brain is maintained
by the vessel autoregulatory system.
CBF can be measured with transcranial doppler ultrasonography (TCD), near-infrared
spectroscopy (NIRS), PET and SPECT (using dedicated tracers), or with CT or MRI
using a contrast agent. Alternatively, CBF can be measured with MRI without use of
contrast media - this method is called arterial spin labeling [12–14].
2.2.3 Cerebrovascular system
Superior 2/3 of brain is supplied mainly by internal carotid artery (70% of blood sup-
ply), inferior 1/3 of brain and brain stem mainly by vertebrobasilar artery (30% of
blood supply). Internal carotid artery then divides mainly into middle cerebral artery
(MCA) and anterior cerebral artery (ACA), vertebrobasilar artery leads blood mainly
to posterior cerebral artery (PCA). MCA, ACA and PCA are connected by communi-
cating arteries in circle of Willis (Figure 2.5). All arteries then branch out to arterioles
and capillary bed (where the exchange between blood and tissue is happening) and
goes back to veins trough venules. Arteries and veins are large vessels with diameter
from 0.1 mm to more than 10 mm. Arterioles and venules are smaller with diameter
from 10-100 µm and capillaries are the smallest with diameter around 5 µm. All vessels
are lined with flattened endothelial cells and all but capillaries have smooth muscles to
adjust lumen for blood flow and pressure regulation.
2.2.4 Cerebrovascular reactivity
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Figure 2.5. Circle of Willis diagram.1)
CVR is described as a compensatory dilatory capacity of arterioles in the brain to the
dilatatory stimulus. It falls to the category of mechanisms that affect radius of vessels
and it is an important mechanism to maintain constant cerebral blood flow during
changes in perfusion pressure. Reaction to different metabolic states of healthy subject
is very rapid and flexible. An impaired CVR is one of the symptoms of various vessel
pathologies and it has been associated with higher risk of stroke [15, 1, 16, 3].
CVR is usually categorized as normal, reduced, and paradoxical (negative) or ”steal
phenomenon”. Negative response refers to impaired cerebrovascular reactivity of the
highest degree. CVR is the key mechanism in our study and it will be described in
details in chapter Cerebrovascular reactivity (3).
2.2.5 Steal phenomenon
Autoregulation reduce vascular tone to satisfy metabolic requirements and keep normal
flow with up to 70% vessel blockage. However, when a vasodilatory stimulus is applied
it can lead to a reduction of CBF in that region – a steal phenomenon. The explanation
is the following. Vessel dilation causes CBF increase in the normal vessels. The ability
of further vasodilation is limited in vessels with impaired CVR. The blood flow follows
the path of least resistance and the tissue that is supplied by vessel that retain the
dilatation ability ”steals” the blood away from impaired area [18]. Sometimes the
tissue keeps partial ability to dilate under small stimulus but when larger magnitude
of stimulus is applied vasodilatory reserve is exhausted and steal phenomenon occurs.
Steal can occur under the folowing circumstances [17]:. two or more intracranial vascular beds of different vasodilatatory capacity,.parallelly perfused from a common blood supply,.flow capacity of the supply vessel is less than that of the vascular beds.
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Figure 2.6. Brain vascular territory scheme. The upper branch is partially stenosed. The
vasodilatory reserves of the vessels are shaded. Note, that the upper branch is already
dilated to maximum while lower branch is not exhausted. A global vasodilatory stimulus
will cause dilation of all vessels except of those in the upper branch that are already at the
maximum of the reserve. This will cause a relative increase of CBF in the lower branch.
However, the post-stimulus CBF in the upper branch will not increase as the blood is
partly re-routed to the lower-branch. This phenomenon is called ”vascular steal” [17].
2.3 Functional MRI
Functional magnetic resonance imaging is a method for studying brain functionality
through MRI signal changes associated with neuronal activity. It became very popular
especially in neurological research because of its good spatio-temporal resolution (Figure
2.7) and complete non-invasiveness.
Figure 2.7. Spatio-temporal resolution of fMRI in comparison with other methods common
in neurological research.
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Functional MRI is used for studying brain activation induced by stimulus or event.
Regions with similar pattern of changes are also studied using resting state fMRI where
the subject does not perform any explicit task. The most common methods to indirectly
measure the neuronal activity are blood oxygen level dependent (BOLD) that measures
changes in blood oxygenation through changes in blood T2* time and arterial spin
labelling that measures the tissue perfusion. Both these methods can, however, be also
used to assess the vessel reactivity and the CVR of vessels through signal changes upon
a vasodilatory stimulus [18].
2.3.1 ASL
ASL is a method for measuring tissue perfusion. In ASL, blood is magnetically labelled
using a 180◦ RF pulse. The labelled blood then decreases the measurable signal in the
perfused tissue. By imaging the tissue with and without prior labelling, we are able
to quantify the perfusion in tissue from the difference image. The advantage compared
with BOLD is the ability to quantify perfusion in standard units, while BOLD measures
a combination of several effects. Disadvantage is lower signal to noise ratio and lower
time resolution [18–19].
2.3.2 BOLD
Rest state Activated state
- normal flow
- rest level [Hbr]
- rest CBV
-normal MRI signal
Figure 2.8. Summary of BOLD change in contrast.1)
BOLD is the most common technique for functional MRI. Measurement is usually
acquired using an EPI sequence over longer period of time. It is based on neurovascular
coupling and magnetic susceptibility of blood. Basics of this method were laid down
by Pauling and Coryell in 1936 when they experimented with magnetic properties of
blood. They found out that magnetic susceptibilities of arterial and venous blood differ
by large amount [20]. It is 20% for completely oxygenated and deoxygenated blood.
These magnetic properties are caused by the presence of iron (Fe) in the haemoglobin
molecule. In oxyhaemoglobin, O2 is bound to Fe and the electron/proton values are
balanced and the molecule has no charge. In deoxyhaemoglobin, the O2 is not bound
to Fe and the molecule has 2 positive charges. Ogawa made an experiment with
a rat and noticed changes in signal during brain activation and measured changes in
deoxyhaemoglobin and oxyhaemoglobin ratio [21]. Magnetic properties of deoxygenated
blood causes inhomogeneities in magnetic field and contraction of blood T2* relaxation
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time of about 1-10% 1). At 1.5 T , oxygenated blood relaxation time is 250 ms while
for deoxygenated blood it is 220 ms[22]. Posse reffered 2.1-fold increase in T2* due
to visual stimulation under 20-50 mmHg end tidal partial pressure of CO2 (PETCO2).
However the functional contrast was lost when PETCO2 was over 70 mmHg [23]. This
difference in T2* relaxation time creates the difference in contrast. See Figure 2.8 for
summary [5, 24–26].
The measured BOLD intensity is highly variable because of contributions from several
functional changes. Several groups have studied the problems of interscan and inter-
subject variability of BOLD and proposed methods for fMRI normalisation including
inhalation of medical gases, calibration task in sensorimotor, visual or auditory area
and its combinations. Liau referred that BOLD have inverse dependence on baseline
CBF while maximal BOLD response is independent of baseline CBF [27]. Thomason
reduced variability of working memory task by 24% with breath hold calibration last-
ing 18 seconds [28]. However calibration in children and in adults is considered not
robust enough because of more noisy response in children [29]. Cohen used inhalation
method to calibrate motoric stimulation under different field strengths (1.5 T , 4 T , 7 T
gradient echo and 4 T spin echo). The tests resulted in consistent results across all field
strengths and sequences [30]. All previous results are in good agreement with Equation
(2.3) from Kim.
The BOLD contrast is affected by changes in cerebral blood flow, cerebral blood volume,
and cerebral metabolic rate of O2 utilization. The change in venous blood oxygenation
level (∆Y ) is is given by:
∆Y
1− Y =
∆CBF/CBF−∆CMRO2/CMRO2
∆CBF/CBF + 1 , (2.3)
where ∆ refers to the stimulus induced change. From (2.3), it can be deduced that
when the relative changes of ∆CBF and CMRO2 are similar then ∆Y will be close to
zero, otherwise the BOLD signal is correlated to CBF. [15, p. 9] If we assume that
haematocrit in venous blood is the same during stimulus, then BOLD signal can be
approximated as:
%BOLD = M
(
1−
(
(1 + ∆CMRO2/CMRO2)
(1 + ∆CBF/CBF
)β (
1 + ∆CBVCBV
))
, (2.4)
where M is a constant related to baseline physiological vascular and imaging parame-
ters. Value for β of 1.5 is commonly assumed [15]. The left term relates to the oxygen
consumption versus CBF change, the right term relates to the relative CBV change,
calculated from Grubb formula (1+∆CBV/CBV) = (1+∆CBF/CBF)α. The value of
α = 0.38 was obtained from anaesthetized monkeys experiments and has been used for
most human BOLD studies [15, p. 9].
From the previous equations,it can be seen that BOLD contrast depends mainly on
cerebral blood flow. This justifies the use of BOLD as a measure for brain metabolism
rate, because CBF delivers the oxygen and glucose to the centres of activation and
carry away the waste products - heat and carbon dioxide.
1) http://fsl.fmrib.ox.ac.uk/fmri_intro/physiology.html
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One have to be careful with interpretation of pixel intensities. MR signal intensity
is a sum of contributions from multiple tissues, each with different spin density and
relaxation times. This problem is even more notable with fMRI because of acquisition
over time where each repetition carry anatomical and functional information. Pixel
position and tissue combination vary with time because of physiological movements such
as breathing, heart rate and also subject movement in scanner, and thus is impossible
to attach particular pixel to precise part of tissue [15, 31].
The text written so far refers to healthy subjects only. However in case of pathological
subjects with lesions, strokes, cerebrovascular disease, etc. the neurovascular coupling
may not respond in expected way and this phenomena is referred to as neurovascular
uncoupling. Although this usually causes true negative activation in fMRI, it can also
lead to false negative activation (BOLD invisible or silent response) or false positive
activation. Both are a serious problem in clinical praxis because they can lead to wrong
estimation of aﬄicted area resulting in worse prognosis on one side and insufficient
treatment on the other side [32–33, 15].
2.3.3 Hyperoxia and hypercapnia
Functional MRI data are highly variable between subjects and even in one subject
between sessions. Thus calibration is recommended to reduce variance. Calibration is
a process which is done before the fMRI acquisition to set the subject in a ”neutral
condition”, to find the metabolism boundaries to have additional data about actual
metabolic state. For calibration, both hypercapnia and hyperoxia can be used.
Hyperoxia is a state when a gas of higher than normal partial pressure of oxygen is
inhaled, usually is considered gas mixture with 25-100% oxygen content. Basic values
for oxygen are in Table 2.2. As mentioned above, oxygen is not dissolved in blood
plasma as much as other gases and haemoglobin is used for transport of oxygen. In
normal conditions, the arterial blood is nearly fully saturated. When the concentra-
tion of oxygen is higher, the extra oxygen is dissolved in plasma causing that venous
haemoglobin is more saturated. This induces measurable changes in the concentration
of oxygenated (saturated) capillary and venous blood.
”Hyperoxia method” for fMRI BOLD calibration involves CMRO2 - CBF coupling and
the approach is based on known oxygen delivery and change in venous blood saturation
while CBF and CMRO2 remains constant [34–35]. However, Chiarelli studied calibra-
tion methods based on hyperoxia, he compared vales of CBF under normoxia versus
100% hyperoxia and measured that the relative reduction of CBF is 7% [36]. In a simi-
lar study, Duong suggests that relationship between O2 and CBF is sigmoidal and that
under hypoxia condition the CBF change is exponential [37]. However, this change is
small and have neglectible effect on hyperoxia calibration.
PaO2 Normoxia Hyperoxia
21% O2 100% O2
mmHg 120.1 657.7
F% 15.8 86.5
Table 2.2. Values of end tidal partial pressure of O2 under hyperoxia and normoxia mea-
sured by Shen and Chiarelli [34, 36] (averaged).
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Hypercapnia is generally defined as a state when partial pressure in blood carbon dioxide
exceeds 45 mmHg. This can be achieved by inhalation of CO2 enriched gas or by
breath hold. CO2 is natural vasodilator and as such stimulates veins in brain to thicker
their lumen to asses homoeostasis. Higher concentration of carbogen dioxide induces
higher blood flow rate. In healthy subject, the reaction in whole brain is global and
proportional to the vascularisation of tissue. Impaired areas, however, react differently
and this can be used for assessing the state of vascular reserve. The reaction depends
on stimulus length and magnitude. In CO2 inhalation, it is the stimulus length and
partial concentration. In breath hold, it depends on the phase when the breathing is
stopped - end-expiration or end-inhalation and how long it is held.
In contrast to hyperoxia, hypercapnic calibration is based on CBF change due to va-
sodilative reaction to the CO2 concentration and CMRO2 is supposed to be constant.
Because of the change in flow, impairment of cerebrovascular reactivity can be assessed
using hypercapnia approach (more in the next chapter). The shape of PETC02 - CBF
dependency is also sigmoidal [37].
Values of BOLD signal intensity, CBF and CMRO2 under different concentration of
CO2 for hypercapnic studies are in Table 2.3 for inhalation and in Table 2.4 for breath
holding.
Gas mixture PETCO2 Fraction BOLD CBF CMRO2
mmHg % % ml/100g µmol/100g
/min /min
ambient air 39.5a 5.2 - 49 [38] 134[38]
4-5% CO2 air 48.2a 6.3 3 [39,40*] 80 [38] 130 [38]
7-10% CO2 air 55b 7.2 2.8 [41] 93.5 [23] -
7-8% carbogen 49.5c 6.5 5.5 [42] - -
Table 2.3. Values of end tidal partial pressure of CO2 under normocapnia and hypercapnia
for different gas concentrations, averaged a[23, 42, 38, 43, 40, 44–45], b[43, 23], c[16, 42], *
measured with a 3 T scanner, other BOLD values with a 1.5 T scanner.
Author Hold Rest PETCO2 BOLD CBF
s s mmHg % ml/100g/min
Kastrupa 18 18 - 2.7 -
30 30 - 3.2 70
30 60 - 3.3 -
36 48 - 2.2 62
* 40 40 - 2.7 -
Murphy[46] 20 30 45 3 -
Table 2.4. Values of end tidal partial pressure of CO2 for different experiments with breath
hold, a[39, 47–49], * breath hold after inspiration, other BH started after expiration.
14
Chapter 3
Cerebrovascular reactivity
CVR is a change of CBF in response to vasoactive stimulus. It is considered a sensitive
indicator of brain’s ability to dramatically adjust energy supply and it is a sensitive
biomarker in aging studies as it can potentially reveal what goes beyond the normal
decline in vessel ability to dilatation [50]. In clinical studies, CVR can predict the
outcome of a bypass surgery, it reflects the severity of several diseases and CVR im-
provement well correlates with improvement of the disease. On the other hand CVR,
is not influenced by typical risk factors for vascular diseases. Schwenrtfeger had stud-
ied changes in the CVR of healthy subjects over time (3 years) using a transcranial
doppler ultrasonography (TCD) and found no significant influencing factors including
gender, age and smoking [12]. In an MRI study, Fierstra evaluated smoking, diabetes,
chronic obstructive pulmonary disease, asthma, hypercholesteraemia and hypertension
and revealed no significant differences in CVR [51].
There are several possibilities how to assess CVR in patients. Clinically, non-invasive
CVR measurements are generally performed using TCD (TCD-CVR) where changes
in blood flow velocity are recorded in the middle cerebral arteries. The TCD mea-
surements is thus insensitive to localized CVR impairment. Alternatively, BOLD-MRI
measurements (henceforth termed BOLD-CVR) can be used to assessed the CVR lo-
cally [52]. There are several options how to create a vasodilatory response necessary
for a CVR measurement. First is to use a vasodilatator (for example acetazolamide)
which is intravenously injected and its effect is observed with imaging modality such as
TCD or MRI. Effect of acetazolamide is dependent on dose and it is easily comparable
between subjects and modalities. The second possibility is regulation of partial pressure
of C02. The effect of acetazolamide and inhalation of CO2 on CVR was compared by
Goode. Both methods showed very good reproducibility. The advantage of CO2 over
the use of acetazolamide is its natural vasodilation and non-invasiveness [41].
The most recent model of the relationship between CBF and arterial partial pressure
of CO2 (PaCO2) was designed by Sobczyk. He had improved the classical model from
60s [53–55] by incorporating more recent concepts of the CBF regulation [17]:.a sigmoidal shape of dependency of CBF on PaCO2,. the vascular regions vasodilate to compensate for decreased perfusion pressure,.vasodilation can lead to exhaustion of vasodilatory reserve, and reduced CVR,.vasodilatory stimulus can increase CBF capacity above the flow capacity of major
vessels,. if capacity of major vessel is overreached, steal phenomena occurs [56].
The model (Figure 2.6) predicts a CBF increase as a response to a vasodilatory stimulus
as depicted in Figure 3.1. However, the same stimulus leads to decrease in blood
flow in a region with reduced vasodilatory reserve. This is referred to as paradoxical
or negative response. The physiological effects of reduced vasodilatory reserve are
altered NVC, decrease in tissue perfusion, and steal phenomenon. This makes the
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Ful vasodilatory reserve
Exhausted vasodilatory reserve
Figure 3.1. Predicted blood flow responses to PaCO2. The solid line depicts the sigmoidal
response of normal vasodilatory reserve. The dotted line depicts the flow in a vessel with
reduced vasodilatory reserve. The values on the ’Blood flow change’ axis are intentionally
neglected because of relative character [17].
CVR measurement a useful marker for detecting abnormalities in patients in risk of
neurovascular disease [51, 57–64], cognition impairement [42] and brain tumours [65,
33]. Reduced CVR is an independent predictor for stroke [52] and may also indicate
tissue exposed to episodic low-grade ischemia [59]. Altered CVR is observed in patients
with Alzheimer’s disease [42], cognitive impairment [42], severe depression [12], epilepsy,
subarachnoid haemorrhage [60], carotid occlusion [66] or transient ischemia [47].
3.1 Hypercapnia fMRI
Blood oxygen level-dependent MRI (BOLD MRI) of hypercapnia-induced changes in
cerebral blood flow is an emerging technique for mapping cerebrovascular reactivity
(CVR). Higher concentration of CO2 causes stimulus that change the lumen diameter,
dramatic especially in small arteries and arterioles. Change of ”pipe” diameter affects
flow and volume of blood. PET studies showed that the arterial cerebral blood vol-
ume change is dominant during hyper- and hypocapnia while the venous cerebral blood
volume change is minimal. Same results can be obtained with an MRI technique -
VERVE1) [15, 37]. Hypercapnia stimulation is safe, well tolerated and technicaly fea-
sible in clinical population with no mayor complications. However, some people may
experience minor symptoms like shortness of breath, headache [50].
Commonly used methods for causing hypercapnia can be divided in two basic categories:
gas inhalation (gas blender containing specific concentration of CO2, distributed with
more or less sophisticated ventilation systems) and breathing manipulation (hyperven-
tilation, deep breathing, breath holding, etc.). Both has its pros and cons. The problem
1) Stefanovic B, Pike, GB (2005), Venous refocusing for volume estimation: VERVE functional magnetic
imaging
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of CO2 enriched gases is the usage of a mask which is not comfortable and it is neces-
sary to have MR-safe technique to deliver gas to the magnet room. Also, calibration
of gas properties such as flow and concentration is needed. Mask has usually inbuilt
gas concentration trackers and the measured curve of delivered gas or PETCO2 can be
used as a regressor for improved data analysis. This lowers the chance of spoiling the
measurement by holding breath in incorrect moment and these results usually have
good reproducibility. The BH has the advantage of being easy to implement as no
dedicated hardware is needed and it can be easily performed during a routine clinical
MR examination. A visual or auditory cue is used to indicate periods of breath-hold
and normal breathing. Full cooperation of the subjects is, however, essential.
Most of the currently published CVR studies use a different combination of the CO22
vasoactive stimulus and settings (field strength, sequence) which makes it difficult to
compare them. However, some general properties are know from other modalities or
stimuli. Hypercapnia is a global stimulus affecting the whole brain, however, the largest
response was measured in the cerebellum and in the visual cortex using both BH and
inhalation stimuli [67, 48, 68, 45]. CVR response to both kind of stimuli is larger in gray
matter and nonsignificant in white matter [45, 47] and larger in male than female [16].
Hypercapnia has a suppressive effect on metabolic rate for oxygen (CMRO2) about
2-13% dependent on length of stimulus [49, 69, 38, 44], which is not problem for CVR,
however, when used in combination with physical or psychical stimuli it can lead to
suppression of functional contrast to such stimuli [23]. Jain used 5% CO2 in air and
the length of stimulus was 3 minutes and concluded that effect of CO2 in CMRO2 is
negligible [38] in agreement with Posse [23].
3.1.1 CO2 inhalation
CO2 enriched gases for inhalation are usually air (5-10% CO2, 21% O2 and rest N2)
or carbogen (5-10% CO2 in O2). For both gas mixtures, a distribution mechanism
is needed. This usually consist of two or three way valves to prevent rebreathing (a
respiratory bag is sometimes used for rebreathing exhaled gas), a mask, and a sensor
for the end tidal CO2 tracking.
A fixed inspired fractional concentration of CO2 does not produce a fixed PaCO2. In-
stead, PaCO2 varies both between subjects and within the same subject because it
depends on the actual metabolic rate and ventilation. For this reason, it is better to
use targeting (the level of CO2 in the mixture is dynamically changed in order to reach
targeted concentration of PETCO2) [57]. Tancerdi verified inhalation experimentally
and the most reproducible results were acquired with targeting CO2 (and O2 in some
cases) concentration in exhaled gas [70]. Spano used CO2 targeting to assess CVR in
large clinical population (294 patients, 434 measurements) and evaluated the diagnos-
tic quality (good, diagnostic but suboptimal and nondiagnostic). They were able to
generate CVR maps for 83.9% of patients. From those, 93% were classified as good,
3.3% as suboptimal and 3.3% as nondiagnostic [50].
The ideal composition of breathed gas was studied extensively. Prisman studied effect
of PETO2 changes on CVR during cyclic changes in PETCO2 (30.4-48.8 mmHg) and
PETO2 (100.6-444 mmHg). BOLD reactivity to PETO2 was smaller than to PETCO2.
However, BOLD reactivity to CO2 changes can still be significantly distorted by PETO2
induced changes in suggesting that PETO2 should be carefully controlled [71]. Hare
compared carbogen and CO2 in air using ASL and BOLD. Both methods were correlated
when using C02. However, this did not apply to carbogen stimulation. Carbogen
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causes both hypercapnia and hyperoxia effects that lead to more complex response
that is complicated to interpret. For this reason, Hare suggested to use CO2 in air
over carbogen for CVR mapping [19]. The length of stimulus typically varies from 1-7
minutes. Yezhuvath compared 1 and 4 min stimulus of CO2 in air. The measured CVR
values were similar in both cases suggesting that the 1 min CO2 inhalation is sufficient
for CVR mapping [45]. Moreover, shorter periods are more convenient as negative
symptoms such as dizziness, shortness of breath or nausea can occur on longer periods
(Spano reported 48 cases of discomfort in 434 examinations (11%) [50].
3.1.2 Breath holding
The main advantage of BH over CO2 inhalation is easy implementation, gradual increase
in CO2 over time which leads to gradual changes in CVR response. The disadvantages
are that during poor task performance the results can be misleading or false, and a
presence of mild hypoxia which is considered to have negligible effect on BOLD signal
[70]. No complication or side effects are associated with BH task. Contraindications
for BH are dementia, language or visual impairment (because of cue) or respiratory
disorders such as emphysema, chronic bronchitis because of elevated baseline CO2 un-
der normal condition. At Hopkins Brain Science Institute the BH protocol has been
successfully implemented in approximately 95% of patients who have undergone routine
clinical BOLD fMRI presurgical mapping examinations during the years 2010-2014 [3].
The main disadvantage of BH is a difficult calibration. The response is affected by
several factors including the length of stimulus, metabolic rate of the patient, size of
lungs, and recent ventilation history. Because of non-linear dependency of PETCO2
on BH time, the effect is complicated to quantify. To obtain the absolute measure of
CVR, the PETCO2 have to be measured during the whole acquisition [57]. However,
for clinical evaluation of the state of cerebral vessels, the absolute value of CVR is not
necessary. The main information about vessel condition is carried not by the magnitude
but by the direction of the BOLD change. It is expected that even a normally perfused
brain can show steal phenomenon in white matter under maximal stimulus because flow
resistance of arteries in white matter is 3-4 times larger than resistance of arteries in
gray matter [3].
The first test in 1995 by Stillman at 4 T with as long breath hold as possible (between
1 and 2 min) showed BOLD signal intensity increase by 4-10%. This was in agreement
with previous tests in TCD [72]. In 1998, Moritz reproduced similar results at 1.5 T
[73]. Magon compared the effect of 9, 15 and 20 second BH. With longer BH, the
variability was reduced and the voxel activation magnitude increased. However, the
difference in 15 and 20 s BF was negligible [74]. In current studies, the length of BH
vary between 10 to 40 s. The recommended length is between 20 - 30 seconds according
to patient control/toleration limit. However, even stimulus as short as 3 s leads to
measurable signal change [33]. The intra-subject variance can be further reduced by
controlloing the whole breathing cycle. This was confirmed by Thomason who controled
the depth of breath during rest and BH [28, 75] and by Bright who experimented with
cued deep breathing which proved to be an alternative to BH [40]. However, the effect
on sensitivity of steal phenomena diagnosticts is yet unknown.
3.1.3 Comparison of CO2 inhalation and breath-holding
Big discussion is held about usage of BH or CO2 inhalation. Both methods have strong
base of studies confirming their correctness. However, there are also many studies
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showing differences between the two methods [3]. In 2001, Kastrup compared using a
gas blender with a 5% CO2 inhalation and repeated breath hold for 36 seconds. Both
methods induced the same BOLD changes and clarified that BHT can be employed
clinically to determine CVR with fMRI [39]. Results were in agreement with previous
TCD studies [76]. Bulte used ASL and BOLD to compare 30s BH and inhalation of 4%
carbogen and 4% CO2 in air. All three stimuli were used for model calibration. Results
suggested, that the CO2 in air is recommended over carbogen and BH. Both methods
can lead to BOLD signal changes because in BH the level of O2 in blood is suppressed
and in carbogen elevated [77]. Tancredi employed ASL measured CBF to validate CVR
using four methods: 1) CO2 targeting; 2) administration of fixed concentration of CO2
mixture with air; 3) BH with physiologic modelling of CO2 accumulation; and 4) BH
with hyperventilation. Methods 1-3 had consistent results in CVR percentage change
while method 4 had significantly lower results. When CVR was calculated as an absolute
change in CBF, methods 2 and 3 had lower value, and method 4 was dramatically
lower. The outcome was that CVR should be measured avoiding hypocapnic conditions.
Targeting resulted in PETCO2 values that were the most consistent in linear range of
CBF vs PETCO2 relationships and in best fit to the CVR sigmoidal shape [70].
3.1.4 Data evaluation
BOLD-CVR with block design is evaluated similarly as standard fMRI using a gener-
alized linear model (GLM). The block curve representing stimulus on/off is convolved
with a haemodynamic response function (HRF) and a CVR statistical map is gener-
ated using regression models (GLM, least square, etc.). Recent studies adopt different
regressors such as PETCO2 measurement, sine-cosine curve, or a respiration response
function (RRF) instead of HRF [78]. Data driven models are also used. Simon devel-
oped a method able to determine quantitative CMRO2 and CBF fluctuation without a
priori knowledge of temporal nature of the stimulus. He used a combination of BOLD
and ASL to measure quantitative changes in CBF and CMRO2 that occur in response
to neural stimuli [79].
Bhogal confirmed in a hypo- to hypercapnic challenge that the sigmoidal model provides
a better fit than the linear model. He also suggested that CVR is non-uniform in brain.
It is not only the amplitude, but also the delay and span of response that varies in
impaired tissue. This might be used in distinguishing between healthy and diseased
tissue [52].
The response to stimulus is in general delayed few seconds [80]. However in BHT, the
delay can be estimated more easily than in motoric or visual stimulation because the
whole brain responds almost identically. Typically, a cross-correlation of regressor and
response is calculated followed by shifting the model by the estimated delay. Generally,
the lag had been established to be around 11 s [81]. Blockley used Fourier analysis
techniques to characterize the delays of the BOLD CVR response, and showed that the
frontal lobe reacted earlier (13.8 s after the start of BH) than the occipital lobe (15.2
s), the mean reaction time for GM was 14.3 s [82]. Alternatively, the temporal pattern
of the signal change in purely venous structure such as superior sagittal sinus can be
used directly as a regressor for analysis which eliminates the need to estimate the delay
[3].
Although the HRF response is commonly used, Birn showed that the response to BH is
slightly different. He designed a new model called RRF using the measured responses
to BH (end exp) in several subjects and data recorded using a respiratory belt [78].
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Murphy experimented with various regressors: simple block, block with time derivation,
PETCO2, sine-cosine and suggested that the best fit was for sine cosine or PETCO2 curve
[46]. Bright simulated poor task performance by taking 6 measurements in one session
with variable BH lengths (10, 15 and 20 s). Additional measurement of PETCO2 was
recorded and used as regressor together with uniform length blocks (20 s) and time-
scaled blocks. Both time scaled and uniform blocks resulted in poor repeatability,
however PETCO2 used as regressor resulted in excellent repeatability [83].
3.2 Patient studies
CVR is an important diagnostic marker. Hypercapnia BOLD-CVR is not yet commonly
used in clinical practice. However, there were already several clinical research studies
done especially in dementia, cerebrovascular disorders and tumours. Most of these
studies were published by the group of Dr. Mikulis. In this Chapter, we summarize the
most important applications and findings done using BOLD-CVR.
3.2.1 Moyamoya Disease
Moyamoya disease is a cerebrovascular disorder caused by blocked arteries at the base
of the brain in the basal ganglia. The name ”moyamoya” means ”puff of smoke” in
Japanese and it describes the look of the tangle of tiny vessels formed to compensate
for the blockage. The disease primarily affects children, but it can also occur in adults.
In children, the first symptom of Moyamoya disease is often a stroke, or recurrent
transient ischemic attacks (commonly referred to as ”mini-strokes”). Adults most often
experience a hemorrhagic stroke due to recurring blood clots in the affected brain vessels
[84].
Heyn compared CVR maps from hypercapnia fMRI and angiography of 11 moyamoya
patients to study relationship between CVR, steal and disease severity. Quantitative
CVR showed direct correlation with impaired vascular supply in moyamoya disease [64].
Conklin compared the apparent diffusion coefficient (ADC) of normal-appearing WM
(in T2-weighted images) between regions with and without steal phenomena. Measure-
ments were done on 12 healthy volunteers and in 22 patients with Moyamoya disease
and unilateral CVR impairment. Negative CVR in WM of control subjects was not
associated with increase of ADC. In patients, ADC was higher in the hemisphere with
negative CVR compared with ADC in the ipsilateral hemisphere and also higher than
ADC in the controls. In patients, ADC was also elevated in regions with negative CVR
compared with the regions with positive CVR. These findings suggest that steal phe-
nomenon observed through negative CVR is associated with low-grade ischemic injuries
before any changes are visible on T2-weighted images [59].
Fierstra noted that patients with moyamoya and stenosis had increased cortical thick-
ness in brain areas exhibiting steal after successful revascularization. 29 subjects at an
average of 11 months after surgery, cortical thickness increased in average by 5.1% in
every successfully revascularized area and the CVR had also improved [57].
3.2.2 Dementia
Alzheimer’s disease (AD) is an age-related, non-reversible brain disorder that develops
over a period of years. Symptoms of AD gradually lead to behavior and personality
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changes, and a decline in cognitive abilities. AD ultimately leads to a severe loss of
mental function. These losses are related to the worsening breakdown of the connections
between certain neurons and their eventual death (as neurons cannot survive when they
lose connections to other neurons). This is manifested as cortex atrophy in the affected
regions [85].
Cantin used 7% carbogen mixture in patients with AD (9), and mild cognitive im-
pairment (7) (MCI), and age-matched controls (11). Carbogen induced whole brain
signal increase in all subjects. However, signal increase in AD (0.36% BOLD/mmHg)
and MCI (0.36% BOLD/mmHg) patients was lower than in healthy controls (0.62%
BOLD/mmHg). CVR impairments were predominant in posterior areas, however, the
mean CVR was the best predictor of the mini-mental status examination [42].
Mikulis observed decrease in CBF in patients with arterosclerotic dementia and senile
psychosis. This decrease was caused by increased vascular resistance with vascular
changes preventing a ”compensatory” increase in blood flow similar as in patients with
advanced stenooclusive disease relationship between exhaustion and cortical thickness
has been established partially reversible after surgical revascularization. Additional
studies have shown that revascularization can improve cognitive decline as well as cog-
nitive function [86].
3.2.3 Stenosis and Aneurism
A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons
out and fills with blood. An aneurysm can press on a nerve or surrounding tissue, and
also leak or burst, which lets blood spill into surrounding tissues (called a hemorrhage).
Cerebral aneurysms can occur at any age, although they are more common in adults
than in children [87].
Stenosis, refers to any condition in which a blood vessel – such as an artery – becomes
abnormally narrow. In the context of stroke, ”stenosis” is usually caused by atheroscle-
rosis, a condition where a blood vessel supplying blood to the brain is narrowed due to
fatty deposits, known as plaques, on the vessel’s inside wall [88].
Mandell compared hypercapnia BOLD and ASL in 38 patients with stenooclusive dis-
ease to confirm that the CVR-BOLD response is directly related to changes in CBF.
Hemispheric CVR was significantly correlated with CBF for both GM and WM (com-
parison was done for paradoxical CVR). This confirms that even in patients with
stenoocclusive disease, the BOLD-CVR reflects changes in CBF [89]. In different study
he suggested a method to predict the hemodynamic effect of extracranial to intracra-
nial bypasss surgery in patients with stenooclusive disease. Group with a normal pre-
operative CVR demonstrated no significant change in CVR after surgery. Group with
reduced CVR demonstrated a significant improvement following bypass surgery. Group
with paradoxial CVR demonstrated the greatest improvement [58].
Costa studied patients at risk of delayed ischemic neurological deficit (DIND). He fo-
cused on whether CVR would detect early radiological markers of vasospasm and DIND.
5 patients with aneurysmal subarachnoid hemorrhage underwent the hypercapnia chal-
lenge for CVR mapping as soon as possible after aneurysm treatment. No patients
showed a vasospasm, two patients had abnormal CVR and subsequently developed
DIND, three had normal CVR of which one developed posterior circulation DIND and
one developed angiographic vasospasm. Costa concluded that changes in CVR 36 h
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after hemorrhage had a good spatial correlation with delayed ischemia during short
term follow up [60].
Chang investigated the variability of the BHT BOLD CVR dynamics in patients with
significant unilateral carotid stenosis undergoing carotid angioplasty with stenting. In
the group (n=5) with poor correlation between hemispheres, defined as impaired CVR,
post-stenting perfusion tended to be more significantly increased, than in group (n=12)
which had similar CVR responses between either hemisphere. The BOLD signal time
curves of the non-stenotic side of the MCA territory were highly correlated with the
average response from a previous study in normal subjects. A collateral circulation
was developing with disease progression. This manifested as a change in the temporal
characteristics of the BOLD signal [61].
Poublanc studied the negative BOLD-CVR response in subjects with steno-oclusive dis-
ease. Dynamic susceptibility contrast MRI was used as the gold standard measurements
of the blood arrival time. The results showed high correlation between both methods.
The most compromised tissue with the longest blood arrival time had the lowest (most
negative) CVR magnitude. Time differences in peak BOLD-CVR response between
healthy and diseased tissue were as long as 30 s in some patients, whereas correspond-
ing blood arrival time differences were on the order of a few seconds. These results thus
support the hypothesis that negative BOLD-CVR is a result of a steal phenomenon
instead of delayed arrival of blood [62].
Fierstra studied relationship between impaired CVR and seizures in 20 patients with
arteriovenous malformation (AVM). AVM is an abnormal connection between arteries
and veins, bypassing the capillary system and epileptic seizures are common in patients
with newly diagnosed brain AVM. BOLD-CVR in brain tissue adjacent to the brain
AVM can help to distinguish between patients with(10) and without(10) seizures. There
is a strong correlation between impaired CVR in brain tissue surrounding the AVM in
the group with the tendency for epileptic seizures. In contrast, patients without seizures
did not show impaired CVR in the tissue surrounding the AVM. The overall CVR in
the seizure-prone group was smaller than that observed in patients with brain AVM
without seizures and in controls (12), however, it still exhibited an increase in BOLD
signal in response to hypercapnia [51].
3.2.4 Tumour
Zaca employed hypercapnia CVR for presurgical mapping in patients selected for lesion
resection. The goal was to maximize lesion extraction while minimising damage to
surrounding tissue. This is usually done using fMRI with visual, motor, cognitive or
somatosensory tasks. However, tumour vasculature responds much less vigorously to
physiological stimuli than vessels in normal cerebral cortex and thus the CVR mapping
is a good alternative diagnostic modality.
Pillai used BH for presurgical plannig to detected regions aﬄicted by low grade glioma.
Glioma has neurovascular uncoupling effect, and CVR mapping is a powerful method
to detect abnormal neurovascular coupling [33]. Neurovascular uncoupling can manifest
as a false-negative activation on BOLD fMRI. This may result in resection of healthy
part of the cortex. NVU can also cause false-positive BOLD fMRI activation causing
insufficient tumor resection. For this reason, detection of NVU in tumor vicinity is
important for interpreting of the BOLD-fMRI findings [3].
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Chapter 4
Materials
In this Chapter, we describe what measurements were done and what patients were
included in the study. The protocol was designed and all the measurements were
carried out at department of Neuroradiology at University hospital Carl Gustav Carus
at Technical University Dresden. The aim of study was to assess the diagnostic potential
of cerebro-vascular-reserve (CVR) mapping in a group of patients using a breath-hold
hypercapnia BOLD. Specifically, to investigate if the CVR impairment can predict later
infarction and how does the CVR pattern change after interventional therapy.
4.1 Patient data
All examinations were performed from February 2008 till September 2010 at the De-
partment of Neuroradiology as a part of the CVR-Study (Study was approved by the
local Ethic Committee, decision from 11.02.2008, EK172072007).
4.1.1 Subjects
Included were the patients of the Neurology Department who had a confirmed stenosis
or occlusion of an extra- or an intracranial vessel. Eligible for this study were patients
who fulfilled the following criteria:.adult age,.ability to give an informed consent,.diagnosis confirmed on computed tomography (CTA), magnetic resonance angiogra-
phy (MRA), time of flight angiography (TOF) or in digital subtraction angiography
(DSA),.more than 50% (measured according to NASCET1) stenosis or occlusion of the inter-
nal carotid artery (extra- (ICA ex) or intracranial (ICA in) segments), the middle
cerebral artery (MCA), the vertebral (VA) or the basilar artery (BA),. stenosis of more than one of the extra- or intracranial arterial vessels was not an
exclusion criteria, in such case a ”target stenosis” was defined. Criteria for choosing
the target stenosis was correlation with clinical symptoms.
Excluded were all patients who:.were not able to give informed consent or were not willing to participate in the study,.were pregnant,.had implants that were not MR-compatible,. suffered from claustrophobia,.had poor prognosis (less than 2 years, for example due to malignancies).
1) North American Carotid Endarterectomy Trial, [90]
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In total, 59 patients were included in the study (mean age 55.0±15.3 years, range 19-81).
There were 31 men (mean age 58.0) and 28 women (mean age 51.7)..20 patients had extracranial stenosis, 39 intracranial,.8 patients had a transient ischemic attack, 34 an ischemic stroke with acute infarction
in the target stenosis region,.17 patients did not have image findings associated with the target stenosis region.
Out of that, 2 patients had a transient ischemic attack and 4 had an acute infarction
in a region corresponding to a stenosis in another vessel than the one with a target
stenosis,. the target stenosis region was ICA ex (n=18), ICA in (n=11), VA ex (n=2), VA in
(n=2), BA (n=3), M1 (n=21), M2 (n=2).
4.1.2 Acquisitions
A 1.5 T Siemens Sonata MRI scanner with an 8-channel head-coil was used for all
measurements. The study protocol consisted of four sequences: fluid attenuated inver-
sion recovery (FLAIR), diffusion weighted imaging (DWI), time-of-flight angiography
(TFA) and hypercapnia BOLD fMRI with a breath-hold task.
The common parameters of the sequences are shown in Table 4.1
Sequence TE TR matrix size voxel size ST SG slices
ms ms pix mm mm mm -
FLAIR 109 9000 384×512 0.45×0.45 5 1.5 19
TFA 7 37 384×512 0.39×0.39 0.8 0 87
EPI DWI 96 3100 128×128 1.8×1.8 5 1.5 19
EPI BOLD 54 3330 384×384 3.28×3.28 4 1.2 26
Table 4.1. Sequence parameters. ST stands for slice thickness, SG is slice gap. EPI DWI
stands for diffusion weighted sequence with calculation of apparent diffusion coefficient.
Hypercapnia BOLD was acquired with a block-design paradigm and a breath-holding
task. Patients were commanded using a microphone to breath normally and to hold
their breath. The phase of normal breathing ended with inspiration and the breath-
holding phase ended with expiration. The patients were not wearing any breathing
mask and the concentration of gases in the expired gases was not measured. The
measurement started with normal breathing which lasted for 10 EPI scans (33.3 s).
Then followed alternating phases of breath-holding (7 scans in each phase, 23.3 s) and
normal breathing (14 scans, 46.6 s). In total, six breath-holding phases were acquired.
Three scans with normal breathing were acquired after the last breath-holding phase.
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Chapter 5
Methods
In this chapter, we describe the whole data processing pipeline (5.1 and 5.2). We
summarize the common approach for hypercapnia data analysis and also introduce a
novel method (5.2.2). At the end of the chapter, we describe the protocol for evaluation
of the quality of results both on patients (5.3). We present here only the principal
aspects of the analysis. The technical details of implementation as well as a simple
manual are given in the appendix.
5.1 Preprocessing
All the analysis was performed in Matlab (The MathWorks Inc., Natick, Massachusetts).
For some routines we have used the SPM8 toolbox (Wellcome Trust Centre for Neu-
roimaging) developed at the Functional Imaging Laboratory at University College Lon-
don [91].
Figure 5.1. Preprocessing diagram. Preprocessing consist of motion correction, registra-
tion to standard MNI template and smoothing with gaussian kernel.
The data were downloaded from the hospital PACS system and converted from DI-
COM to NIFTI format using the dcm2nii program1). During this process, all patient
information were anonymized and a unique patient ID and session ID were assigned to
each dataset to allow backward identification and interpretation of clinical findings.
1) http://www.mccauslandcenter.sc.edu/mricro/mricron/dcm2nii.html
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5.1.1 Motion correction
The patients in this study were mostly elderly and all had a severe cerebro-vascular dis-
ease. Given that a breath-holding task had to be performed during the fMRI measure-
ment, slight movement during the acquisition was inevitable. As a first preprocessing
step, we had therefore corrected for head motion to reduce unwanted variance in the
voxel space. The Realign tool from the SPM toolbox was used for this purpose.
Realignment involved a six parameters (x,y,z translations and rotations - pitch, roll, jaw)
affine transformation. The procedure looked for optimal parameters that minimize the
displacements between each scan and a reference scan (first one) by using a sum-of-
square differences of the intensities in the two volumes. The data were then re-sampled
using the transformation with estimated parameters and B-spline interpolation. All
parameters are listed in Table 5.1 [92].
Estimate Reslice
Parameter Value Parameter Value
Quality 0.9 Which all
Separation 4mm Interpolation reslice 4 deg B-spline
Smoothing 5mm kernel Wrap reslice no
Num Passes 1 Mask 0
Interpolation 2 deg B-spline
Wrap no
Table 5.1. Setup of motion correction - Realign: Estimate and Reslice.
For each subject, the maximal absolute change was calculated for all parameters and
patients moving excessively were identified. As a threshold for excessive movement, we
considered 5 mm in transition and 5◦ in rotation.
5.1.2 Spatial normalization
For several reasons, we have decided to perform spatial normalization to the MNI space.
First, it compensates for different positioning of a patient on different sessions and thus
allow easier evaluation of follow up studies. Second, it simplifies operations with the
atlas of vascular regions. And lastly, it eases the intersubject comparison and clinical
evaluation when the slices are parallel with the AC-PC plane. The Normalize tool from
SPM8 was used for this purpose. The algorithm is based on minimizing the the sum of
squares difference between the processed image and EPI template aligned to the MNI
space using a 12-parameter affine transformation followed by a nonlinear deformation.
A mean image of the whole series was used for estimation of the warping parameters
[92]. The resulting voxel size was chosen as 3× 3× 5 mm3.
5.1.3 Smoothing
Smoothing with Gaussian kernel has several effects. It decreases the level of noise
(improves signal to noise ratio) and it renders the error distribution to be more close to
normal distribution. The image resolution is reduced, however, this step is justified by
the fact that hypercapnia fMRI data typically show large spatial correlations of adjacent
voxels (2.4) and large regions of pathological behaviour. Smoothing was performed with
a 6 mm FWHM Gaussian kernel.
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Estimate Write
Parameter Value Parameter Value
Template image EPI.nii (SPM8) Preserve all
Source image smoothing 6 mm kernel Bounding box [ -78 -112 -50;
Template image smoothing 6 mm kernel 78 76 85]
Affine regularisation ICBM space template Interpolation 2 deg B-spline
Nonlinear frequency cut-off 25 Wrapping no
Nonlinear iterations 16
Nonlinear regularisation 1
Table 5.2. Setup of registration to standard anatomical space - Normalise.
5.2 Data analysis
The automatic processing pipeline was implemented in Matlab. Two methods were used
for data evaluation, however, most processing steps were common for both methods and
it mainly differed in the choice and preprocessing of the regressors.
The first method is model-driven and it uses convolution of the block response function
with haemodynamic response function (HRF) for regression analysis (in the pipeline
called HRF method). The second method uses a data-driven approach and uses the
region with ’Best Fit’ to the expected block response as regressor (thus called BF
method in the pipeline).
Figure 5.2. Processing diagram. The images are masked with binary mask first. Then
the methods differ in regressor preparation: model-driven approach uses a model of ex-
pected response, data-driven approach uses response from region that has the most similar
behaviour as the expected response. See Section 5.2.2 for details. After regression analy-
sis, cerebrovascular reactivity maps are overlaid over anatomical image and displayed as a
’lightbox’ matrix.
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5.2.1 Masking
To assess only data from brain structures, the non brain structures were masked out
using a binary mask of the brain from the SPM template. Additionally, the mean
response of the whole brain and mean response over regions of interests (ROI) were
calculated. As ROIs we used different vascular territories. It is possible to choose
between mask with 7, 11 or 15 regions in the processing pipeline. For both methods we
used the seven-region mask which was designed by supervising neurologist describing
the localization of basic neurovascular regions. This mask consist of regions supplied
by four vessels – left and right anterior cerebral artery (ACA), middle cerebral artery
(MCA), posterior cerebral artery (PCA), and both vertebral arteries excluding PCA
regions (VA). The mask is in the Figure 5.8. The two other maps are in the Appendix
(9.1 and 9.2).
5.2.2 Regression analysis
CVR map was calculated using least squares fitting (LSQF) of a regressor function to
the measured preprocessed data. The CVR response M was obtained independently in
each voxel by minimizing the following (Mx,y,z, α ∈ IR):
min
M,α
∑
t
(Ix,y,z,t −Mx,y,z · rx,y,z,t − α)2,
The CVR response was thus estimated as:
Mˆx,y,z =
∑
t (rt − µr) · (Ix,y,z,t − µI)∑
t (rt − µr)2
, (5.1)
Mˆ is the resulting CVR-map, x, y, z are the image coordinates, t is time, I is the mea-
sured 4 dimensional fMRI image and r is the regressor, µ stands for mean of regressor
and image, respectively, and αˆ is neglected for the clinical evaluation.
Primary response
Negative
overshoot
Time
4-8s
Initial dip
Stimulus
onset
MR
signal
Figure 5.3. The basic haemodynamic response function1).
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Model-driven approach
This approach uses standard block function indicating periods of normal breathing
and breath-holding convolved with a HRF for regression analysis. Additionally after
preprocessing and masking, the data were averaged over whole brain to obtain a mean
response curve (Equation(5.2))
Rest =
∑
x
∑
y
∑
z (Ix,y,z,t · bx,y,z)∑
x
∑
y
∑
z bx,y,z
, (5.2)
Rest is the response for time t, x, y, z are the image coordinates, I is the measured 4
dimensional fMRI image, b ∈ {0, 1} denotes the binary mask.
This was used for subject-wise delay correction (each subject has an individual delay of
response to stimulus based on metabolism, previous inhalation pattern etc.). Averaged
response was filtered with low-pass filter (convolution with Gaussian window length
31 scans, σ = 0.8) to remove noise and high-pass filter (Gaussian window length 31
scans, σ = 10) for drift reduction. Then it was scaled so the minimum and maximum
was equal 0 and 1 (to allow easier visual comparison of regressor and mean response
curves). For each patient, the cross correlation between mean response and regressor
was calculated to identify the subject’s delay. The ideal delay is the maximal cross
correlation from regressor and mean response in time (Equation (5.3)).
(Res ? r)[d] ≡
n∑
t=0
Rest · r[t+d] (5.3)
d is the delay in our case from -3 to +3, r is regressor, Res is mean response, t is time
and n is the number of scans (125 in our case). The ideal lag is the [d] of maximal cross
correlation of mean response and regressor.
Then the regressor was shifted according to the calculated delay to fit the particular
subject’s response. The shifted regressor curve was then used for generating a CVR
map using LSQF (Equation (5.1)).
time [scan]
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re
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1
Figure 5.4. The mean curve (blue), regressor (dot-dashed black) and shifted regressor
(black).
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Data-driven approach
This method is novel in the field of BOLD-CVR analysis and it is the key contribution
of this thesis. In this method, we assume that except for small variations, the healthy
CVR response from all brain regions is similar. Moreover, we assume that each patient
has at least a single large region which exhibits a normal CVR to hypercapnia. We
base our assumption on the work of Goode and Chang Ting who were comparing CVR
between hemispheres [41, 61]. Using the response from this region as a regressor should
prove more efficient than using an expected model response in case the subject does
not adhere to the breathing-protocol completely.
Similar steps as in the model-driven approach were performed first. The data were
masked with a binary brain mask. Then the data were separated by ROI mask into
7 regions and mean response was calculated for each region (Equation (5.4)). Region
responses were then filtered to remove drift and high-frequency noise.
Rest,k =
∑
x
∑
y
∑
z(Ix,y,z,t ·ROIx,y,z,k)∑
x
∑
y
∑
z ROIx,y,z,k
, (5.4)
Res is the response, x, y, z are the image coordinates, t is time, I is the measured 4
dimensional fMRI image, k ∈ {0, 1, ..., 7} is the ROI identifier
Then, the Pearson’s correlation coefficient (PCC) between the block-function convolved
with HRF and region-wise response was calculated for each ROI, see Equation (5.5).
Example of mean region responses are shown in Figure 5.5 for a subject with no CVR
impairement and in Figure 5.6 for a subject with regions of impaired CVR.
PCCrt,ROIk,t =
∑
t
(rt − µrt)(ROIk,t − µROIk,t)
σrtσROIk,t
, (5.5)
where µ is mean and σ stands for standard deviation, r and ROI are regressor and
mean ROI response respectively, t is time (scan number) and k is ROI identifier.
time [scan]
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Figure 5.5. The mean responses over
ROI’s in a subject with no CVR impaire-
ment. The ACAR region have the largest
PCC.
time [scan]
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Figure 5.6. The mean regional responses
in a subject with impaired CVR in the left
MCA territory (red). The MCAR territory
has the largest PCC.
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The region with the largest PCC was considered as the reference region since it showed
highest correlation with the expected healthy response. It was assumed that this region
had the most normal CVR response. The mean response from this region was filtered
to remove noise and drift and the amplitude was normalized similarly as in the model-
driven approach. This filtered response was then used as regressor for LSQF(Equation
(5.1)).
5.2.3 Results visualisation
Resulting CVR maps were overlaid over the anatomical images. Anatomical images
were acquired by fluid-attenuated inversion recovery (FLAIR) or by T2 or T1 weighted
spin echo sequences, in case that for particular subject FLAIR was not available. CVR-
maps were displayed in ’jet’ colormap with 40% opacity and they were upsampled to
the same resolution as the high-resolution structural images. The result was then saved
as .png containing 20 selected axial slices (position of the selected slices is shown in the
Figure 5.9) ordered as ’lightbox’ matrix. An example of four slices is shown in Figure
5.7.
Figure 5.7. CVR map. Four slices are shown for a subject with CVR impairement in the
left MCA territory. Larger CVR-response is in green-yellow to red colors (highest response)
and low CVR response and paradoxical response is in blue (arbitrary units).
Combination of functional and anatomical information eases the diagnostic process in
way that neurologist can link bad functional response to anatomical abnormalities in
particular brain area. The processing pipeline allows selection of number (9,12,16 and
20) and position of the displayed slices (see Appendix 9.2). All slices are selected
in order to contain slices at ganglionic level and slices at supra ganglionic level for
evaluation by ASPECTS 1) grading.
5.3 Method comparison
The aim of the clinical study was to evaluate the diagnostic potential of CVR induced
by BH. This included evaluation of the patient reaction to therapy and comparison
with changes in CVR maps. The contribution of this thesis was an implementation
of a standard and an advanced method for data analysis and showing which method
has the best diagnostic potential. We have therefore analyzed the results and focused
only on the patients manifesting differences between the results of the methods. When
the model-driven and data-driven methods gave identical clinical findings, we have
1) http://www.aspectsinstroke.com/
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Figure 5.8. The mask with 7 basic regions
of interests dark blue/blue – ACA; light-
blue/green – MCA; yellow/orange – PCA;
red – VA.
Figure 5.9. Slices selected for visualiza-
tion.
considered their diagnostic potential equal and we did not further examined if this
finding is correct as this will be a goal of an upcoming clinical study.
The clinical part of the study was supervised by two neuroradiologists (3 y and 10+
y of experience) who recorded the patient data and clinical findings and assessed the
stenosis locations from the TOF images.
5.3.1 Criteria
First, the overall image quality was scored on grade from 0-2 (0 unreadable, 1 subop-
timal, 2 optimal quality). Quality of CVR-maps was assessed based on the following
criteria: sufficiently high SNR, high contrast between WM and GM, absence of CVR
signal in CSF (although presence of vascular plexus had to be excluded).
Then, the pathological regions on CVR-maps were identified as showing zero or negative
response, or showing response that was clearly decreased when compared to contra-
lateral side or to overall response amplitude. The regions with reduced CVR were
assessed separately in the right and left hemisphere and regions with decreased CVR
were identified and marked according to the ASPECTS program. The CVR-maps
that scored 0 on quality-check were not evaluated, however, the pathological regions in
patients with quality 1 were assessed.
5.3.2 Readings
First, the CVR maps were evaluated by a board of 3 physicians. The board consisted
of two neuroradiologists (10 y experience; 4 y experience with 10 y experience in radi-
ology) and a neurologist (10 y experience in neurology) with stroke and neuroimaging
fellowships. All the raters were blinded to the clinical findings, patient clinical history,
the target stenosis region and finding from other imaging modalities. The data from
the first session only from 58 patients were evaluated in two sittings. The raters were
shown the CVR-map of the model-driven method only. After reaching consensus, the
FLAIR image was shown and the infarct regions were identified and recorded according
to ASPECTS.
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More than one month later, the patients that scored 0 and 1 on model-driven quality
check were re-evaluated using the BF method. Only the data-driven CVR maps were
shown and the FLAIR and model-driven maps were not re-evaluated. First, all patients
that scored 0 on model-driven were evaluated and then all the patients that scored 1
on model-driven. Both the quality of the data-driven CVR maps and the pathological
regions according to ASPECTS were recorded.
The quality and pathological regions were assessed also by a medical physicist with 5+
y experience with neuroradiological images. The rater assessed images from all patients
in all sessions (153). He was blinded to the clinical findings, patient clinical history,
the target stenosis region and finding from other imaging modalities. The images were
displayed in completely randomized order to blind the rater to the method, session and
patient number. Only after the whole analysis was finished, the correct method, session
and patient number was assigned to the findings to allow further evaluation.
5.3.3 Evaluation
After the rating, the sessions and patients numbers were assigned to appropriate score
tables. The diagnostic quality of CVR maps and the difference in pathological regions
was then assessed.
First, we have summarized the quality scores only. We have calculated how both
methods scored in quality and we have counted the number of session in which the
quality increased or decreased. Note that for the ratings by the board of medical
doctors the data-driven evaluation was not available for all sessions in which model-
driven scored 2 on quality.
Second, we have checked the results for differences in the findings as well. We have
focused on sessions, where either the pathological regions or the quality of the images
in the data-driven and model-driven methods differed. The cases where the quality
and findings were identical were not considered, because we were primarily interested
in comparison of model-driven and data-driven analysis in terms of better diagnostics
and not in the overall evaluation of suitability of hypercapnia BOLD for clinical use. If
the findings for both methods were different we have done the following to assess which
of the findings are closer to reality (most important are first):. In one of the other sessions acquired for the same patient, both methods scored 2
and had identical findings – these findings were considered as ground truth. It can
happen for certain subjects that there are no more findings or that the regions with
impaired CVR are smaller in later session as an effect of treatment. This was taken
into account..The findings corresponded with the location of infarct (assessed as hyperintensity in
FLAIR images in the readings by the board of physicians)..The findings corresponded to the primary or secondary stenosis (assessed from the
TOF images by the physicians supervising the study).
For certain subjects it was, however, not possible to objectively decide which method
offers better results while there was only one session obtained, there was no pathological
findings in the latter sessions, or the stenosis or infarct region did not correspond to
the results of neither of the methods. The comparison thus led to the following cases:. Improved findings – model-driven and data-driven methods differ in the pathological
regions found on the CVR map. One was clearly indicated as better based on the
findings from other sessions or modalities.
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.Same findings – The independent scoring of pathological regions is in complete agree-
ment between both methods, however, the quality was scored differently. Although
the reading of the better CVR map is easier and more reliable, it did not have a
direct effect on the pathological region classification..Undecided – The pathological regions differ and it is not possible to decide which
finding is more correct from the available information.
All the results are summarized and shown in the Table 6.1 and 6.2.
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Chapter 6
Results - evaluation
In this chapter, you can find results from the preprocessing – motion correction 6.1,
and processing – delay correction 6.2. And most importantly, the results from methods
evaluation in quality 6.3 and diagnostic potential 6.4 assessed by both a board of physi-
cians and a medical physicist, in this part are presented graphical outputs of several
example cases.
6.1 Motion
In preprocessing step, the motion correction with 6-parameter transformation was per-
formed with 3 parameters for transition and 3 for rotation. The criteria for excluding
the subject from analysis was 5 mm for transition or 5◦ for rotation. Figure 6.1 shows
the distribution of maximal value in both categories for all patients. The maximal
transition was 3.8 mm and maximal rotation 3.7◦. No subject was thus excluded from
the analysis because of excessive motion.
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Figure 6.1. Distribution of the motion across subjects. Whiskers stand for minimum and
maximum, the box denotes the first quartile and the third quartile, and red line is median.
In total, 8 sessions had translation or rotation larger than 2mm or 2◦. These sessions
were checked for evaluation of quality with the following results: 25% had score 2-2,
50% scored 1-2, in 12.5% the score was 2-1 and in the remaining 12.5% it was 0-0. It
thus seems that larger motion is not an important factor that would prevent successfull
analysis of the hypercapnia-BOLD data.
6.2 Delay
An individual delay of the response was calculated for each patient to reflect both
the individual reaction time to command and the delay of BOLD response to breath-
holding. This was done by calculating maximum cross-correlation of mean patient
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response and the regressor, see Figure 6.2. We can observe that the delays fall into
three categories: a) around 0 scan (0 sec)) – the true variation in the response time;
b) around 9 scans (cca 30 sec) – this corresponds roughly to half of a breathing phase;
c) around 15 scans (cca 50 sec) – this cluster contain only one value and corresponds
to a shift by one breathing phase. The shift by a half-phase and full-phase have no
physiological background and are probably caused by having too large regions with a
paradoxical reponse or problems in the breathing protocol. To avoid half and whole
phase shift, the estimation was limited to -3,3 scans in the processing pipeline. Resulting
delays are plotted in the Figure 6.3.
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Figure 6.2. Response delays. Clusters
of following values are visible in the Fig-
ure: around 0 – corresponding to true
delay, around 9 – half phase shift and
one value with 15 – shift by the whole
breathing-phase.
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Figure 6.3. Response delays across all
subjects when estimation was limited to
delays between 3 and -3 scans to avoid
non-physiological shifts by a half phase
and full phase.
6.3 Quality evaluation
The first evaluated parameter was the overall quality of the CVR maps. Quality was
scored as 0 – Unreadable (Figure 6.4), 1 – Suboptimal and 2 – Optimal quality (Figure
6.6). The scoring followed the process as described in (Section 5.3.2). Quality as well as
diagnostic potential were evaluated by a board of physicians and by a medical physicist.
Figure 6.4. In the model driven approach, the CVR-map appear like a random noise. In
DDA method, some structure is visible. However, the are artifacts on the rim around the
brain and there appears to be high CVR in the ventricules - therefore the map was also
evaluated as non-diagnostic. Two slices are shown for each method.
The patient in Figure 6.4 scored 0 on quality in both MDA and DDA. The poor quality
of the CVR maps is probably caused by problems with breathing, see Figure 6.5.
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Figure 6.5. No pattern similar to the expected healthy response (dashed light blue) is
visible in the mean brain response (blue full). This can be possible attributed to the
subject’s poor performance during the breath-holding task.
Images of different qualities in two patients are shown in Figure 6.6. In the top row, a
patient with a Moyamoya disease improved quality from 0 with MDA to 2 with DDA
and in the bottom row the patient with small stenosis from 1 with MDA to 2 with
DDA. This patient is a typical example of breathing protocol violation, see Figure 6.7
- top. The mean response from the vascular territory supplied by the vertebral artery
as assessed by DDA is shown in the Figure 6.7 - bottom. You can see that subject held
breath only four times instead of six times and that the beginning and end of BH phase
did not fully correspond to the model regressor. The MDA analysis therefore failed,
but it was still possible to create reasonable CVR maps using the DDA method.
Figure 6.6. Comparison of the DDA and MDA quality for two patients (two different slices
are shown for each subject). In the top row, the MDA analysis was scored with quality 0
and the CVR-map is not diagnostic (left). The DDA method was scored with quality 2
and a CVR impairment is visible in the anterior to central part of the right hemisphere.
In the bottom row, the findings were identical for both MDA (quality score 1) and DDA
methods (quality score 2). However, the DDA-maps show better contrast between gray
and white matter and appear less noisy.
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Figure 6.7. The top graph: the mean response (blue line) of the subject is very noisy
and does not correlate with regressor (light blue - dashed line). The bottom graph: the
mean response of the best region of the DDA method – vertebral artery territory. For
convenience, the hypercapnic periods are marked manually.
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Figure 6.8. Quality evaluated by the
board of physicians. For model-driven
method: 27 – ’Optimal’, 21 – ’Subopti-
mal’, 10 – ’Unreadable’. In data-driven
method chart are displayed only results
for sessions that were ’Suboptimal’ or
’Unreadable’ in model-driven CVR-map.
From the 31 evaluated BF-maps was
7 – ’Optimal’, 17 – ’Suboptimal’, 7 –
’Unreadable’.
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Figure 6.9. Change of quality between the
model-driven and data-driven CVR-maps.
Only the 31 sessions that did not scored
’Optimal’ from model-driven CVR-maps
were considered. 15 sessions were evalu-
ated equally in both readings, 2 improved
from ’Unreadable’ to ’Optimal’, 5 from
’Suboptimal’ to ’Optimal’ and 5 from
’Unreadable’ to ’Suboptimal’. In 4 cases,
the quality worsened.
6.3.1 Board – quality
From 58 subjects analysed with the model-driven method, 27 (47%) were evaluated
as ’Optimal’ and data-driven CVR map was not re-evaluated. 21 (36%) model-driven
CVR-maps were marked as ’Suboptimal’ and 10 (17%) were ’Unreadable’. Re-evaluation
of the data-driven CVR-maps was done with 31 subjects of which 2 (6%) improved
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quality by 2 grades, 10 (32%) improved by 1 grade, 15 (48%) had same grade, and in
4 (13%) cases the quality worsened by 1 grade. Result for quality are summarized in
Figure 6.8 where all grades are counted and Figure 6.9 which considers only the results
that were not marked as ’Optimal’ from the model-driven CVR-map.
6.3.2 Physicist – quality
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Figure 6.10. Quality evaluated by the
physicist. For model-driven: 111 – ’Opti-
mal’, 24 – ’Suboptimal’, 18 – ’Unreadable’.
In data-driven method chart are displayed
only results for sessions that were ’Sub-
optimal’ or ’Unreadable’ in model-driven
CVR-map. From 42 evaluated data-driven
CVR-maps was 31 – ’Optimal’, 6 – ’Sub-
optimal’, 5 – ’Unreadable’.
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Figure 6.11. Change of quality between
model-driven and data-driven CVR-maps.
Only the 42 sessions which did not scored
’Optimal’ from model-driven CVR-maps
were considered. 10 sessions was evaluated
equally in both methods, 12 improved
from ’Unreadable’ to ’Optimal’, 19 from
’Suboptimal’ to ’Optimal’ and 1 from
’Unreadable’ to ’Suboptimal’. In 2 cases
the quality worsened.
The same quality evaluation was done by a medical physicist who evaluated all 153
sessions. The CVR-maps were randomized in both method, patient, and session iden-
tification. From 153 sessions, 111 (72%) scored ’Optimal’ in model-driven method, 24
(16%) scored ’Suboptimal’ and 18 (12%) ’Unreadable’. In the data-driven method, 140
(92%) sessions were ’Optimal’, 8 (5%) ’Suboptimal’ and 5 (3%) ’Unreadable’. From 42
session with score 0 and 1 at the first reading 12 (27%) improved quality by 2 grades,
20 (45%) improved by 1 grade, 10 (23%) had the same grade, and in 2 (5%) the quality
worsened.
6.4 Evaluation of diagnostic potential
Differences in the diagnostic potential of both methods was assessed by marking the
impaired regions Section 5.2.2 and then scoring the differences according to Section
5.3.3. As in the previous section, the diagnostic quality was evaluated by both board
and physicist. Three states of results were achieved: 1) Improved findings – the impaired
regions differ and it can be decided which is more correct – points are given to the
method with better findings; 2) Same findings – the findings are same for both methods
– points are given for quality; 3) Undecided – findings are different and it is not possible
to clearly decide on the correct one – points are given based on quality. The results are
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Figure 6.12. Three patients for which both methods give the same results in the same
quality (two slices are shown for each subject). No CVR impairement is visible for the
patient in the first row. CVR impairment in the MCA territory in the left hemisphere
is visible for the patient in the middle row. This corresponds to the findings from other
modalities - the patient had a stenosis in at the M1-L segment and infarct in the M4
region). Similar situation is for the patient in the last row. CVR impairment is clearly
visible in the right hemisphere. The patient had a stenosis in the M1-R segment and an
infarct in the M3 and M5 regions.
summarized in Tables 6.1 and 6.2. In the Figure 6.12 three patients with equal quality
are shown. The first has no impairement of CVR visible. The second and third have
CVR impairment in the left hemisphere and in the right hemisphere, respectively.
6.4.1 Board – diagnostic potential
In the board evaluation, only the sessions which did not score ’Optimal’ in HRF maps
were evaluated also for BF maps and thus allowed the method comparison. From the
31 session, in 8 cases was the diagnostic potential better in the BF method, and in 5
(3) cases in the HRF method. In 5 (7) sessions the findings were equal but differed in
quality, and in 5 cases (of which 3 were unreadable in both methods) was not decided
which method is better. In 10 cases, the same findings and scores were reported. In 3
cases, the results were different, however, images looked completely the same. This is
marked as a number in brackets in Table 6.1 and is contributed to the error in rating.
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Better Quality Improved Same Undecided Sum Final
method MDA-DDA findings findings score
data 0-1 4 1 0 5
driven 0-2 2 0 0 2
1-2 1 4 0 5
same 1 1 13
model 1-0 2(1)a 0 2 2(1)
driven same 4(2) 0 3(2)b 5(3)
none 0-0 3 0 0
Table 6.1. Results from the board of physicians; 0 – ’Unreadable’, 1 – ’Suboptimal’, 2 –
’Optimal’; a,b – images are identical, a in 1 case, b in 2 cases; In the sessions which scored
as ’Optimal’ for model-driven CVR-maps, the quality and diagnostic potential was not
evaluated. (MDA – model-driven approach; DDA – data-driven approach)
6.4.2 Physicist – diagnostic potential
Here, we show the comparison of both methods on the data evaluated by the medical
physicist. In total, there was 42 sessions that have different quality, findings or both.
In 16 cases, the diagnostic potential was better in the data-driven method, in 3 cases in
the model-driven method. In 13 sessions, the findings were equal, however, the quality
differed. In 13 cases, it was not decided which method brings better results (5 of these
case were unreadable for both methods, 3 cases had the same quality for both methods).
In 5 cases, the data-driven method showed less sensitivity to the impaired CVR than the
model-driven method in the follow-up sessions, and thus showing a more improvement
by the treatment than the model-driven maps showed Figure 6.13. Patient underwent
a stent treatment and the CVR improvement after surgery is visible in the CVR-maps.
The progress is shown on three sessions, two before and one after surgery.
Better Quality Improved Same Undecided Sum Final
method MDA-DDA findings findings score
data 0-1 0 0 1 1
driven 0-2 6 5 1 12
1-2 6 7 3 16
same 4 4 33
model 1-0 0 0 0 0
driven 2-0 0 0 0 0
2-1 1 1 0 2
same 7 (2)a 7 (2) 9 (4)
none 0-0 5
same 3
Table 6.2. Results from the randomized evaluation by a medical physicist; 0 – ’Unread-
able’, 1 – ’Suboptimal’, 2 – ’Optimal’; Unlike in the evaluation by the board of physicist,
the quality and findings were available for both methods for all sessions for all patients.
In 5 cases, the data-driven method showed less sensitivity to the impaired CVR than the
model-driven method in the follow-up sessions, and thus showing a more improvement by
the treatment than the model-driven CVR-maps showed. (MDA – model-driven approach;
DDA – data-driven approach)
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Figure 6.13. CVR improvement for a single patient after stent treatment is shown in three
session. The patient had a extracranial stenosis of the left ICA. The CVR impairement is
clearly visible for both methods. On the second session, some CVR impaitement is still
visible, though the DDA method is less sensitive in detecting it. On the third session, the
CVR impairement is no more visible in the CVR maps of both methods.
6.5 Methods evaluation – summary
With the data-driven method, the overall quality of CVR maps improved in 12 cases out
of 31 (39%) and in 32 out of 42 (76%), in the evaluation by the board of physicians and
by the medical physicist, respectively. In the board evaluation, there was 17% (10 out
of 58) unreadable cases in the model-driven method evaluation, and 10% (3 out of 31) in
the data-driven method. In the physicist evaluation, there was 12% unreadable in the
model-driven method and 3% in data-driven method. In the ’Improved findings’ case,
the data-driven was correct in 55% (66%1) (6 out of 11) cases in the board evaluation
and 66% (16 out of 24) (84%2) cases in the physicist evaluation.
Score Board Physicist
MDA DDA MDA DDA
Quality improvement 13% 39% 5% 76%
Unreadable cases 17% 10% 12% 3%
Diagnose correct 45% (34%) 55% (66%) 34% (16%) 66% (84%)
Final score 5 (3) pts 13 pts 9 (4) pts 33 pts
Table 6.3. Summary of the results. Quality improvement – in how many cases the quality
improved between methods; Unreadable cases – how many sessions scored 0; Improved
findings – how many cases were correct for the particular method. Final score – from tables
6.1 and 6.2 (pts – points; MDA – model-driven approach; DDA – data-driven approach).
1) not considering the case of 3 sessions that were evaluated differently while the images were identical
2) not considering the 5 cases of lesser sensitivity of data-driven in the follow-ups after treatment
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Chapter 7
Discussion
In this work, we have reached all the main goals set in the thesis proposal. The data
were successfully acquired and processed and the output were CVR maps that could
be directly used in evaluation of CVR impairment. Moreover, we have designed and
implemented a novel method for data-driven processing of hypercapnia BOLD data,
that was shown to give more reliable results than the standard method of evaluation. We
have, however, faced several challenges during the implementation and evaluation which
are discussed in this section. We also give directions in which the future development
of our method can go to obtain even better results.
7.1 Delay
For analyzing the response delay, two methods were used. The first was a subject-wise
correction (SWC) which shifts the regressor in time to the point of largest correlation
with mean patient response. We have also tried a pixel-wise correction (PWC) method
which shift data in each voxel in time to the point of largest correlation with the regres-
sor. The PWC method aimed to compensate for region-wise delays as demonstrated
by Blockley (the time-difference in response in temporal and frontal areas was shown
to be up to couple of seconds [35]). We have, however, observed that the CVR-maps
generated using the pixel-wise correlation method had reduced sensitivity to detecting
impaired regions. This is supported by the findings of Bhogal that the impaired re-
sponse of CVR have different temporal characteristics than the healthy one [52]. For
this reason, we have used only the subject-wise delay correction in the final evaluation.
A solution to this problem might be to use a designated regional delays based on mean
regional delays calculated in healthy subjects.
7.2 Regressors
Apart from the model-driven and data-driven methods described in previous section,
several other regressors were implemented (e.g. HRF with time derivative [46], a
respiratory-response function (RRF) [78]). However, no significant changes of qual-
ity were observed, thus these methods were not included in the comparison.
It is interesting to note the difference between end–inspiration and end–expiration meth-
ods of breath holding. The end–expiration is used more frequently though it is less
comfortable for the subjects. The reason is that the increase of CO2 is faster and thus
the response has shorter delay than in end–inspiration. The response has similar shape
as the haemodynamic response function (figure 7.1) and thus is more easily modelled
by classical approach of convolving box function with HRF curve. On the other hand,
breath holding after inspiration takes less effort for the examined subjects. This was
the reason why we chose it for our study. However, the BOLD response contains one
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additional smaller peak. This probably occurs because of sudden oxygen saturation, see
Figure 7.2. This complicates the analysis, as this smaller peak is often present also in
pathological regions that otherwise have a paradoxical response in hypercapnia-BOLD.
We have developed an advanced data-driven method that tries to remove the smaller
peak from the data-driven method regressor to reduce the effect of this on the CVR
analysis (method RP in the processing pipeline). Although we have failed to improve
the results significantly, we strongly believe, that looking at the response during inspira-
tion and during breath-holding separately can bring additional important information
in the hypercapnia-BOLD evaluation.
time
MR
signal
Figure 7.1. Shape of response to breath
hold after expiration.
time
MR
signal
Figure 7.2. Shape of response to breath
hold after inspiration.
The ideal option to verify the performance of model-driven and data-driven methods
would be to test the methods on healthy volunteers and introduce artificial errors in the
breath-holding protocol (missed breath-holds, errors in timing etc.) while measuring
also the concentration of exhaled CO2 using a capnometer as this gives an almost ideal
regressor for CVR evaluation.
We have also tested an iterative method for data analysis. In the first iteration, the
model driven approach was used. The voxels showing significant positive activation were
assumed to belong to healthy tissue. Their time response was averaged and used as a
regressor in the following iteration. This was repeated until convergence (the difference
between the sets of activated voxels between iterations was less than 10 voxels). We
have, however, not observed any major changes in the results of the DDA and iterative
method.
7.3 Evaluation
Both evaluations gave a clear result that the proposed method (DDA) can offer at least
the same quality of the results as the MDA method in the fully-cooperating subjects.
Moreover, it can significantly improve the quality in the case of a subject that deviates
from the breathing protocol. There are, however, several shortcomings of the evaluation
procedure performed.
While the TOF and FLAIR can in most cases confirm the findings from hypercapnia
BOLD, it cannot be taken as ground-truth for the CVR-impairment evaluation. Pres-
ence of infarct should imply also CVR impairment, however, it does not necessarily
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work the other way around. The impaired CVR most probably imply stenosis, how-
ever, the stenosis does not necessarily cause decrease in CVR. A reliable ground-truth
can be obtained by measuring the concentration of the exhaled CO2 as well for reference
which we plan to in the future.
In 72% cases(153 sessions), the resulting quality was 2 for both DDA and MDA. In 47%
cases(58 sessions), the quality was 2 on MDA and thus it was not assessed for DDA.
However, the main point of interest are the cases ’Improved findings’, ’Same findings’
and ’Undecided’ which contributed the most for the comparison of the efficiency of the
two methods. There, a the DDA method performed better in the majority of cases.
Only in few cases, it was not possible to decide what findings from which method are
more reasonable.
In the evaluation by the board of physicians, three patients were evaluated as having
a better diagnostic quality in the MDA images (DDA quality score 0, MDA quality
score 1). While reviewing the results, we have noted that the DDA and MDA maps
were identical identical. This can be thus attributed to the error of the raters. Careful
reviewing of other cases have not revealed any other similar error.
In the medical-physicist evaluation, the quality evaluation the diagnostic potential was
done first. Then, the findings from multiple sessions in one patient (if available) were
compared to find pathological regions that were visible throughout all sessions and thus
be able to decide about correctness of findings in individual sessions if the quality of
the map was questionable. The later session were usually measured after treatment the
CVR improved in most of the subject. In 5 cases in one of later sessions, MDA proved
higher sensitivity in detecting pathological regions than the DDA method. While still
some small regions with impaired CVR were visible on the MDA-maps, they were
smaller or even appeared completely normal in the DDA method. However, this kind
of findings was visible only in the follow-up sessions and would thus not have a great
impact on the diagnostics.
In total, 3 cases in physician evaluation and 5 cases in physicist evaluation had score 0
for both methods. The reason in all cases was identified as too low SNR in the mean
response (no detectable pattern of normal breathing and breath-holds was visible).
The possible reason is that these patients did not held breath for sufficiently long time
or completely skipped several BH periods. Interestingly, the physicist and physicians
independently marked only 1 session as unreadable for both methods. Three cases were
not evaluated by the board of physicians, two and one cases were marked as readable
by at least one of the methods by the physicist and the physicians, respectively.
An further experimental validation of method is planed to be done on healthy subjects.
A similar measurement to the current one will be done while measuring also the con-
centration of CO2 in exhaled gas. This would allow a more rigorous comparison of the
MDA and DDA methods as the CVR-maps obtained using the CO2 curve as a regressor
are close to the ground-truth. Poor performance of the subjects will be simulated by
intentionally not doing all BH tasks, by delayed response to commands, by ending the
BH prematurely or by hyperventilating between BH periods.
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Conclusion
All the goals from the thesis specification were accomplished as further specified by the
following list:.Learn the principles of functional MR imaging and data processing.The basics of MRI and fMRI are briefly described in Chapter 2..The theory and already published methods for assessing CVR with hypercapnia
are described in Chapter 3.Design and implement a method for evaluation of hypercapnia sequences, to distin-
guish between normal and pathological regions..A pipeline for automatic processing of hypercapnia BOLD data was implemented.
The inputs are BOLD EPI and FLAIR images in DICOM format and the output
is a CVR-map overlayed over a FLAIR image normalized to the MNI template
(Section 5.2)..A standard evaluation of the vascular response assuming the block design ex-
periment was implemented. The individual delays in the patients response to
commands were corrected for (Section 5.2.2)..A novel data-driven approach which robustly evaluates the data even when the sub-
ject is not following the measurement protocol precisely was implemented (Section
5.2.2)..Experimentally evaluate the developed method on provided clinical data..The CVR-maps were calculated on a group of patients to provide an additional
information for a clinical study of patients with cerebrovascular pathology (Section
5.3)..The quality of the CVR-maps for the standard and novel analysis were compared.
The pathological findings of the two methods were also compared (Sections 6.3
and 6.4) and a clear improvement of the proposed method was shown.
The proposed data-driven approach is a promising tool to assess CVR in clinical pop-
ulation. It gives reasonable results in case the standard analysis completely fails given
that the patient did not deviate too much from the breathing protocol and he held
breath for sufficiently long time. The quality of the CVR-maps improved in 39% cases
(out of 31 session which scored 0 or 1 on MDA; physicians) and 76% cases (out of 42
session which scored 0 or 1 on MDA; physicist) using the new method and in 66% it
also improved the pathological findings.
However, the data-driven approach also fails in the situations when the subject did not
hold breath for sufficient time to generate an adequate response or did deviate from
the protocol in any other way. Further investigation has to be carried out to assess the
diagnostic benefit of using this method and to do a more thorough analysis on a larger
number of subjects.
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Analysis on a healthy volunteers comparing the MDA, DDA and a method using a
PETCO2 curve as a regressor is planned to have a ground-truth observation and to be
able to more thoroughly compare the methods in the presence of various complications
in the acquisition process. It is not expected that the data-driven approach would
exceed the quality of the results that uses the PETCO2 curve as a regressor, however, the
proposed method nevertheless brings a very important improvement in the hypercapnia-
BOLD analysis. Its main strength is that this method can be easily implemented in
the processing pipeline of any clinical station. Whereas the PETCO2 measurement is
a complicated process and the hardware is not commonly available and very much
complicates the hypercapnia-BOLD to be widely used.
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Appendix
9.1 The Bloch equations
The Bloch equations describe what is detected in the receiver coil of an MRI scanner.
Matrix-vector notation:
d
dt
MxMy
Mz
 =
 − 1T2 γBz −γBy−γBz − 1T2 γBx
γBy −γBx − 1T1
 ·
MxMy
Mz
+
 00
M0
T1
 , (9.1)
nuclear magnetization M = (Mx,My,Mz) in external magnetic field B = B0 + B1
experienced by nuclei, z component of B is composed of two terms B0 is main magnetic
field, constant in time and B1 may be time dependent and helps with spatial decoding
of the NMR signal. γ is a gyromagnetic ratio. M0 is the steady state magnetization.
9.2 Masks and slice selection
Figure 9.1. 10 ROI mask: 1,2 – ACA; 3,4
– MCA; 5,6 – PCA; 7,8 – BA, 9,10 ACHA;
designed by the supervising physician.
Figure 9.2. 15 ROI mask:1,2 – ACA; 3,4
– MCAA; 5,6 MCAM; 7,8 – central; 9,10
– MCAP; 11,12 – PCA; 13,14 – vert, 15
– vermis; designed by author in need for
detailed region map with approximately
same size.
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Figure 9.3. Slices 9 Figure 9.4. Slices 9 version b
Figure 9.5. Slices 12 Figure 9.6. Slices 16
9.3 Codes
In this section, we describe the functionality of the most important scripts in Matlab.
We also describe the outputs and inputs of the analysis software and we provide a
simple manual on adding and analyzing a new subject with the methods. Matlab, SPM
and dcm2nii have to be installed.
For proper function of all scripts, the analyzed data have to be in following folder
structure:
data
- CVR_000
- - Session_00
- - - dicom
- - - CVR_000_Session_00_SHIFT_METHOD_MASK
- - - original_CVR_000_Session_00.nii
- - - roriginal_CVR_000_Session_00.nii
- - - s6wroriginal_CVR_000_Session_00.nii
- - - meanoriginal_CVR_000_Session_00.nii
- FLAIR
- - dicom
- - - CVR_000_FLAIR.nii
Preprocessing: Only input necessary to specify in the preprocess_launcher.m is the
path to the file. Preprocessing generates multiple files in the ../Session_00 folder,
however the important one is with prefix s6wr.
Processing: The setting is done via script modelDesign.m which allows multiple pa-
rameters to be changed:
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26 %% basic settings
27 % model
28 resultfolder=’results/’ %lsqf results folder
29 curv={ ’hrf’, ’hrf2’, ’rrf’, ’rrf2’, ’mean’}; %initial regressor
30 shif={’SWC’,’PWC’}; %shift method
31 shiftRange=[0, 2, 3 ];% maximal shift range
32 bestfit={’off’,’on’, ’BP’, ’RP’}; % bestfit setting/peak removeal
33 ROImask=[7, 10, 15]; % region mask, default 7 regions
34 scalp=[1,0]; % scalp as one of the regions
35 dt=[1 0]; % include time derivation of regressor in analysis
36 iter=[1 2 3]; % iteration
37 P=’spmRes0001’; %iteration calculated in pixels activated at
38 % ’spmRes05’, ’spmRes01’,’spmRes001’
39
40 %% parameters for extraction SPM8 analysis
41 thresDesc=’FWE’; % - ’FWE’ or ’none’ - family wise error correction
42 thresholdCluster= 10; % - minimal size of activated cluster
43 c=[1 -1; 0 0]; % -contrast
44 th=0.0001; % treshold
Visualization: Is run trough plots.m. Only the input and output folders, and number
of slices in the visualization needs to be specified.
9.4 Analyze new subject
Here is a simple cookbook on how to analyze a new subject:
1. Download DICOM files using dicom2ecat program to a new patient folder (note that
this program is specific for our site and a different interface to access the PACS
system has to be used on different site):
a) ../data/CVR_xyz/Session_cd/dicom (for EPI),
b) ../data/CVR_xyz/FLAIR/dicom (for FLAIR)
2. Transform DICOM files to NIFTI using a script: /preprocessing/dicom2nifti.m
(variant for EPI, FLAIR/Single, Multiple). Names of all directories to be processed
needs to be specified on names.txt.
3. Do the preprocessing:
a) for EPI - use the preprocessing routine using preprocess_launcher.m,
b) for FLAIR only spatial normalization is needed. This is done using SPM: Nor-
malise: Estimate and Write with voxel size [0.3,0.3,6.5] - necessary for future
coregistration! If no anatomical image is available, mean of EPI can be used in-
stead. The mean EPI file is created during preprocessing routine - copy it to
the FLAIR folder, do the registration as specified above and rename the result to
’CVR xyz FLAIR.nii’.
4. Processing: script named modelDesign.m allows multiple settings. Mandatory input
is the list of directories to be processing names.txt. The script saves multiple files
according to settings described above. To save CVR maps for several slices in png
coregistered to anatomical image, use a script named plots.m.
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9.5 Folder system
Here is a list of all matlab file with a brief description of the function of each of it. The
files are organized into directories according to the function. The following notation is
used: (s) for script, (f) for function.
codes
| - preprocessing
| | - dicom2nifti.m"(s): runs dcm2nii program with pre-set parameters
| | - walker.m"(f): used by "dicom2nifti.m" when run on folder tree
| | - preprocess_launcher.m(s): runs SPM8 preprocessing
| | - realign.m(f): realign parameter file
| | - normestm.m(f): normalize - estimate paramter file
| | - normwrite.m(f): normalize - write parameter file
| | - smoothing.m(f): smoothing parameter file
| | - foldercheck.m(f): supporting function checks file content
| - motion
| | - motion.m(s): extract movement info from files generated by realign
| | - motionstat.m(s): calculates movement statistics
| | - statplot.m(s): visualisation tool
| - processing
| | - modelDesign.m(s): setting up all parameters for data analysis
| | - names.txt: contains the names of sessions to be analyzed
| | - makeModel.m(f): runs all the processing according to modelDesign
| | - curves.mat: file containing the initial regressors
| | - getmean.m(f): mean curve calculation
| | - meanOverROI.m(f): mean curves in ROI calculation
| | - removeDrift.m(f): highpass filter
| | - filtration.m(f): lowpass filter
| | - crosscorrreduced.m(f): subject-wise lag calculation and shift
| | - pixelWiseCrosscorr.m(f): pixel-wise lag calculation
| | - shiftpix.m(f): pixel wise shift
| | - getBestROI.m(f): sets the ROI with the best PCC as regressor
| | - corrcoef.m(f): pearsons correlation coeficient calculation
| | - lsqfitting.m(f): generate CVR-map as *.nii
| | - lsqf.m"(f): calculates least square fitting
| | - spm_analysis.m(f): setting paramters for spm8 data analysis
| | - saveimg.m(f): saves semi results and results
| - temp_reg
| | - BasicLabels.nii: 7 ROI mask
| | - MediumLabels.nii: 10 ROI mask
| | - DetailedLabels.nii: 15 ROI mask
| | - TMP.nii: 6 masks for GM, WM, CSF, scalp, bone and head
| | - skalp.nii: scalp mask
| - results_extr
| | - resut_extract.m(f): extracts results from SPM data analysis
| | - fMRIContrasf(f): search for active voxels
| | - spm_...(f): modified spm functions for manipulating NIFTI files
| - plot
| | - plots.m(s): runs function plotresult.m on selected files
| | - plotresult.m(f): creates FLAIR CVR-map overlay and saves
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9.6 List of abbreviations
ACA . Anterior Cerebral Artery
AD . Alzheimer’s Disease
ASL . Arterial Spin Labelling
ATP . Adenosine Triphosphate
AVM . ArterioVenous Malformation
BA . Basilar Artery
BOLD . Blood Oxygen Level Dependent
CBF . Cerebral Blood Flow
CMRO2 . Cerebral Metabolic Rate for Oxygen
CTA . Computed Tomography Angiography
CVR . Cerebral Vessel Reactivity
DIND . Delayed Ischemic Neurological Deficit
DSA . Digital Subtraction Angiography
FLAIR . Fluid Attenuated Inversion Recovery
fMRI . functional Magnetic Resonance Imaging
GLM . Generalized Linear Model
HR . Haemodynamic Response function
HRF . Haemodynamic Response Function
ICA . Internal Carotid Artery
LSQF . Leas SQuares Fitting
MCA . Middle Cerebral Artery
MCI . Mild Cognitive Impairment
MRA . Magnetic Resonance Angiography
MRI . Magnetic Resonance Imaging
NVC . Neurovascular Coupling
PaCO2 . Arterial Partial Pressure of CO2
PETCO2 . End Tidal Partial Pressure of CO2
PCA . Posterior Cerebral Artery
PCC . Pearsons Correlation Coefficient
PET . Positron Emission Tomography
PWC . Pixel-Wise Correction
ROI . Region Of Interest
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SNR . Signal to Noise Ratio
SPECT . Single Proton Emission Tomography
SWC . Subject-Wise Correction
TCD . Transcranial Doppler Ultrasonography
TE . Echo Time
TOF . Time Of Flight angiography
TR . Repetition Time
VA . Vertebral Artery
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